2o8y:A   (GLY198) to   (SER336)  APO IRAK4 KINASE DOMAIN  |   PROTEIN KINASE, IMMUNODEFICIENCY, INFLAMMATION, TRANSFERASE 
2o8y:B   (GLY198) to   (SER336)  APO IRAK4 KINASE DOMAIN  |   PROTEIN KINASE, IMMUNODEFICIENCY, INFLAMMATION, TRANSFERASE 
3e62:A   (GLY861) to  (GLN1003)  FRAGMENT BASED DISCOVERY OF JAK-2 INHIBITORS  |   DRUG DISCOVERY, JAK2, FRAGMENT BASED, ATP-BINDING, DISEASE MUTATION, KINASE, MEMBRANE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, PROTO- ONCOGENE, SH2 DOMAIN, TRANSFERASE, TYROSINE-PROTEIN KINASE 
1na7:A    (SER51) to   (PHE181)  CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF HUMAN PROTEIN KINASE CK2  |   CK2, PROTEIN KINASE, MICROCRYSTALS, THIN-FILM NANOTECHNOLOGY, MICROFOCUS ESRF, TRANSFERASE 
4gub:A    (SER51) to   (PHE181)  CASEIN KINASE II BOUND TO INHIBITOR  |   KINASE, TRANSFERASE, CYTOSOL, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4gva:A    (GLY35) to   (VAL171)  ADP-BOUND FORM OF THE ERK2 KINASE  |   MITOGEN-ACTIVATED PROTEIN KINASE, TRANSFERASE 
4gvj:A   (GLY909) to  (GLU1050)  TYK2 (JH1) IN COMPLEX WITH ADENOSINE DI-PHOSPHATE  |   KINASE, HYDROLASE 
2oid:B   (GLY198) to   (ALA335)  CRYSTAL STRUCTURE OF IRAK4 KINASE DOMAIN COMPLEXED WITH AMPPNP  |   KINASE, TRANSFERASE 
2ojj:A    (GLY35) to   (VAL171)  CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH (S)-N-(1-(3- CHLORO-4-FLUOROPHENYL)-2-HYDROXYETHYL)-4-(4-(3- CHLOROPHENYL)-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE  |   KINASE INHIBITOR, TRANSFERASE 
4wno:A    (ALA28) to   (GLN173)  STRUCTURE OF ULK1 BOUND TO AN INHIBITOR  |   KINASE, AUTOPHAGY, INHIBITOR, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3eid:A    (GLY16) to   (GLY153)  CDK2/CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR  |   CDK2, CYCLIN, ATP-BINDING, CELL CYCLE, CELL DIVISION, KINASE, MITOSIS, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SERINE/THREONINE- PROTEIN KINASE, TRANSFERASE, NUCLEUS, TRANSFERASE-CELL CYCLE COMPLEX 
3eid:C    (GLY16) to   (GLY153)  CDK2/CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR  |   CDK2, CYCLIN, ATP-BINDING, CELL CYCLE, CELL DIVISION, KINASE, MITOSIS, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SERINE/THREONINE- PROTEIN KINASE, TRANSFERASE, NUCLEUS, TRANSFERASE-CELL CYCLE COMPLEX 
3ej1:A    (GLY16) to   (GLY153)  CDK2/CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR  |   CDK, CYCLIN, KINASE, ATP-BINDING, CELL CYCLE, CELL DIVISION, MITOSIS, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE, NUCLEUS, TRANSFERASE-CELL CYCLE COMPLEX 
4h3p:A    (GLY37) to   (VAL173)  CRYSTAL STRUCTURE OF HUMAN ERK2 COMPLEXED WITH A MAPK DOCKING PEPTIDE  |   KINASE DOMAIN, SIGNALING, LINEAR MOTIF, SURFACE MUTATION, TRANSFERASE 
4h3q:A    (GLY37) to   (ALA174)  CRYSTAL STRUCTURE OF HUMAN ERK2 COMPLEXED WITH A MAPK DOCKING PEPTIDE  |   KINASE DOMAIN, SIGNALING, LINEAR MOTIF, SURFACE MUTATION, TRANSFERASE 
2ow3:A    (GLY68) to   (GLN206)  GLYCOGEN SYNTHASE KINASE-3 BETA IN COMPLEX WITH BIS- (INDOLE)MALEIMIDE PYRIDINOPHANE INHIBITOR  |   KINASE-INHIBITOR COMPLEX, TRANSFERASE 
2oxd:A    (SER51) to   (PHE181)  PROTEIN KINASE CK2 IN COMPLEX WITH TETRABROMOBENZOIMIDAZOLE K17, K22 AND K32 INHIBITORS  |   KINASE, INHIBITOR COMPLEX, TRANSFERASE 
2oxy:A    (GLU55) to   (PHE181)  PROTEIN KINASE CK2 IN COMPLEX WITH TETRABROMOBENZOIMIDAZOLE DERIVATIVES K17, K22 AND K32  |   PROTEIN KINASE CK2, INHIBITORS, TETRABROMOBENZOIMIDAZOLE DERIVATIVES, TRANSFERASE 
2oxy:B    (SER51) to   (PHE181)  PROTEIN KINASE CK2 IN COMPLEX WITH TETRABROMOBENZOIMIDAZOLE DERIVATIVES K17, K22 AND K32  |   PROTEIN KINASE CK2, INHIBITORS, TETRABROMOBENZOIMIDAZOLE DERIVATIVES, TRANSFERASE 
2b7a:A   (GLY861) to  (GLN1003)  THE STRUCTURAL BASIS OF JANUS KINASE 2 INHIBITION BY A POTENT AND SPECIFIC PAN-JANUS KINASE INHIBITOR  |   KINASE, TRANSFERASE 
2b7a:B   (GLY861) to  (GLN1003)  THE STRUCTURAL BASIS OF JANUS KINASE 2 INHIBITION BY A POTENT AND SPECIFIC PAN-JANUS KINASE INHIBITOR  |   KINASE, TRANSFERASE 
3eoc:A    (GLY16) to   (GLY153)  CDK2/CYCLINA COMPLEXED WITH A IMIDAZO TRIAZIN-2-AMINE  |   CDK, CYCLIN, ATP-BINDING, CELL CYCLE, CELL DIVISION, KINASE, MITOSIS, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE, NUCLEUS, TRANSFERASE-CELL CYCLE COMPLEX 
2b9f:A    (GLY25) to   (ILE161)  CRYSTAL STRUCTURE OF NON-PHOSPHORYLATED FUS3  |   TRANSFERASE 
2b9j:A    (GLY25) to   (ILE162)  CRYSTAL STRUCTURE OF FUS3 WITH A DOCKING MOTIF FROM FAR1  |   TRANSFERASE 
1ny3:A    (LEU79) to   (THR215)  CRYSTAL STRUCTURE OF ADP BOUND TO MAP KAP KINASE 2  |   MAP KAP KINASE 2, MK2, ADP, KINASE, SER/THR KINASE, TRANSFERASE 
4ww5:A    (ILE29) to   (SER189)  CRYSTAL STRUCTURE OF BINARY COMPLEX BUD32-CGI121 IN COMPLEX WITH AMPP  |   KEOPS, BINARY COMPLEX, BUD32-CGI121, TRNA T6A, TRANSFERASE 
4ww9:A    (ILE29) to   (SER189)  CRYSTAL STRUCTURE OF BINARY COMPLEX BUD32-CGI121 IN COMPLEX WITH ADP  |   KEOPS, BINARY COMPLEX, BUD32-CGI121, TRNA T6A, TRANSCRIPTION 
4wwa:A    (ILE29) to   (VAL188)  CRYSTAL STRUCTURE OF BINARY COMPLEX BUD32-CGI121  |   KEOPS, BINARY COMPLEX, BUD32-CGI121, TRNA T6A, TRANSFERASE, HYDROLASE 
3erk:A    (GLY35) to   (VAL171)  THE COMPLEX STRUCTURE OF THE MAP KINASE ERK2/SB220025  |   TRANSFERASE, SERINE/THREONINE-PROTEIN KINASE, MAP KINASE, ERK2 
4hge:A   (GLY861) to  (GLN1003)  JAK2 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 8  |   PROTEIN KINASE, PHOSPHOTRANSFER, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4hge:B   (GLY861) to  (GLN1003)  JAK2 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 8  |   PROTEIN KINASE, PHOSPHOTRANSFER, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3eyg:A   (LEU891) to  (THR1030)  CRYSTAL STRUCTURES OF JAK1 AND JAK2 INHIBITOR COMPLEXES  |   JAK KINASE, ATP-BINDING, KINASE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SH2 DOMAIN, TRANSFERASE, TYROSINE-PROTEIN KINASE 
2bkz:A    (GLY16) to   (GLY153)  STRUCTURE OF CDK2-CYCLIN A WITH PHA-404611  |   TRANSFERASE/COMPLEX, PROTEIN KINASE, TRANSFERASE, SERINE/THREONINE-PROTEIN KINASE, PHOSPHORYLATION, CELL DIVISION, CYCLIN, ATP-BINDING, CELL CYCLE, MITOSIS, POLYMORPHISM 
2bkz:C    (GLY16) to   (GLY153)  STRUCTURE OF CDK2-CYCLIN A WITH PHA-404611  |   TRANSFERASE/COMPLEX, PROTEIN KINASE, TRANSFERASE, SERINE/THREONINE-PROTEIN KINASE, PHOSPHORYLATION, CELL DIVISION, CYCLIN, ATP-BINDING, CELL CYCLE, MITOSIS, POLYMORPHISM 
2bpm:C    (GLY16) to   (PHE152)  STRUCTURE OF CDK2-CYCLIN A WITH PHA-630529  |   PROTEIN KINASE, TRANSFERASE, SERINE/THREONINE-PROTEIN KINASE, PHOSPHORYLATION, CELL DIVISION, CYCLIN 
3f5x:A    (GLY16) to   (GLY153)  CDK-2-CYCLIN COMPLEX WITH INDAZOLE INHIBITOR 9 BOUND AT ITS ACTIVE SITE  |   KINASE, PKC, PROTEIN KINASE, INHIBITOR, ATP-BINDING, CELL CYCLE, CELL DIVISION, MITOSIS, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE, CYCLIN, NUCLEUS, TRANSFERASE-CELL CYCLE COMPLEX 
3f5x:C    (GLY16) to   (GLY153)  CDK-2-CYCLIN COMPLEX WITH INDAZOLE INHIBITOR 9 BOUND AT ITS ACTIVE SITE  |   KINASE, PKC, PROTEIN KINASE, INHIBITOR, ATP-BINDING, CELL CYCLE, CELL DIVISION, MITOSIS, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE, CYCLIN, NUCLEUS, TRANSFERASE-CELL CYCLE COMPLEX 
3s95:B   (GLY351) to   (VAL486)  CRYSTAL STRUCTURE OF THE HUMAN LIMK1 KINASE DOMAIN IN COMPLEX WITH STAUROSPORINE  |   STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC, PROTEIN KINASE, LIM DOMAIN KINASE, TRANSFERASE-ANTIBIOTIC COMPLEX 
3sa0:A    (GLY37) to   (VAL173)  COMPLEX OF ERK2 WITH NORATHYRIOL  |   NORATHYRIOL COMPLEX, SIGNAL-REGULATED KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
2bva:B   (VAL335) to   (VAL465)  CRYSTAL STRUCTURE OF THE HUMAN P21-ACTIVATED KINASE 4  |   PROTEIN KINASE, STE20, PAK4, ATP-BINDING, TRANSFERASE 
2phk:A    (ARG35) to   (PRO176)  THE CRYSTAL STRUCTURE OF A PHOSPHORYLASE KINASE PEPTIDE SUBSTRATE COMPLEX: KINASE SUBSTRATE RECOGNITION  |   CATALYTIC MECHANISM, DIMERIZATION, PHOSPHORYLASE KINASE, REVERSIBLE PHOSPHORYLISATION, SUBSTRATE RECOGNITION, COMPLEX (TRANSFERASE- PEPTIDE), COMPLEX (TRANSFERASE-PEPTIDE) COMPLEX 
4hvg:A   (GLY834) to   (LEU976)  JAK3 KINASE DOMAIN IN COMPLEX WITH 2-CYCLOPROPYL-5H-PYRROLO[2,3- B]PYRAZINE-7-CARBOXYLIC ACID ((S)-2-HYDROXY-1,2-DIMETHYL-PROPYL)- AMIDE  |   KINASE-INHIBITOR COMPLEX, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
2pmi:C    (THR20) to   (GLY159)  STRUCTURE OF THE PHO85-PHO80 CDK-CYCLIN COMPLEX OF THE PHOSPHATE- RESPONSIVE SIGNAL TRANSDUCTION PATHWAY WITH BOUND ATP-GAMMA-S  |   CYCLIN-DEPENDENT KINASE, CYCLIN, SIGNALING PROTEIN,TRANSFERASE-CELL CYCLE COMPLEX 
1oiu:A    (VAL17) to   (ALA151)  STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH A 6-CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR  |   KINASE, TRANSFERASE, SERINE/THREONINE-PROTEIN KINASE, ATP- BINDING, CELL CYCLE, CELL DIVISION, MITOSIS, PHOSPHORYLATION 
1okv:A    (GLY16) to   (GLY153)  CYCLIN A BINDING GROOVE INHIBITOR H-ARG-ARG-LEU-ILE-PHE-NH2  |   KINASE-CYCLIN COMPLEX, CYCLIN A, INHIBITOR, LIGAND EXCHANGE, DRUG DESIGN, PEPTIDOMIMETICS, CELL CYCLE, KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3fl5:A    (SER51) to   (PHE181)  PROTEIN KINASE CK2 IN COMPLEX WITH THE INHIBITOR QUINALIZARIN  |   PROTEIN KINASE CK2-INHIBITOR COMPLEX, ATP-BINDING, KINASE, NUCLEOTIDE-BINDING, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE 
1ol2:C    (VAL17) to   (GLY153)  CYCLIN A BINDING GROOVE INHIBITOR H-ARG-ARG-LEU-ASN-(P-F-PHE)-NH2  |   CELL CYCLE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX, CYCLIN A, LIGAND EXCHANGE, PEPTIDOMIMETICS, KINASE 
1om1:A    (SER51) to   (PHE181)  CRYSTAL STRUCTURE OF MAIZE CK2 ALPHA IN COMPLEX WITH IQA  |   CK2, IQA, INHIBITOR, ZEA MAYS, TRANSFERASE 
2pvh:A    (GLU55) to   (PHE181)  STRUCTURE-BASED DESIGN OF PYRAZOLO[1,5-A][1,3,5]TRIAZINE DERIVATIVES AS POTENT INHIBITORS OF PROTEIN KINASE CK2  |   STRUCTURE-BASED DRUG DESIGN, ENZYME-INHIBITOR COMPLEX, CASEIN KINASE II, PROTEIN KINASE CK2, TRANSFERASE 
2pvj:A    (GLU52) to   (PHE181)  STRUCTURE-BASED DESIGN OF PYRAZOLO[1,5-A][1,3,5]TRIAZINE DERIVATIVES AS POTENT INHIBITORS OF PROTEIN KINASE CK2  |   STRUCTURE-BASED DRUG DESIGN, ENZYME-INHIBITOR COMPLEX, CASEIN KINASE II, PROTEIN KINASE CK2, TRANSFERASE 
2pvk:A    (GLU55) to   (PHE181)  STRUCTURE-BASED DESIGN OF PYRAZOLO[1,5-A][1,3,5]TRIAZINE DERIVATIVES AS POTENT INHIBITORS OF PROTEIN KINASE CK2  |   STRUCTURE-BASED DRUG DESIGN, ENZYME-INHIBITOR COMPLEX, CASEIN KINASE II, PROTEIN KINASE CK2, TRANSFERASE 
2pvn:A    (SER51) to   (PHE181)  STRUCTURE-BASED DESIGN OF PYRAZOLO[1,5-A][1,3,5]TRIAZINE DERIVATIVES AS POTENT INHIBITORS OF PROTEIN KINASE CK2  |   STRUCTURE-BASED DRUG DESIGN, ENZYME-INHIBITOR COMPLEX, CASEIN KINASE II, PROTEIN KINASE CK2, TRANSFERASE 
4i5c:B   (GLY887) to  (THR1030)  THE JAK1 KINASE DOMAIN IN COMPLEX WITH INHIBITOR  |   KINASE, TRANSFERASE 
1opk:A   (GLU274) to   (MET407)  STRUCTURAL BASIS FOR THE AUTO-INHIBITION OF C-ABL TYROSINE KINASE  |   TRANSFERASE 
1opl:A   (GLU274) to   (MET407)  STRUCTURAL BASIS FOR THE AUTO-INHIBITION OF C-ABL TYROSINE KINASE  |   TRANSFERASE 
3fpm:A    (LEU79) to   (THR215)  CRYSTAL STRUCTURE OF A SQUARATE INHIBITOR BOUND TO MAPKAP KINASE-2  |   3D-STRUCTURE, ATP-BINDING, ALTERNATIVE SPLICING, KINASE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, POLYMORPHISM, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE 
2c5o:A    (GLY16) to   (GLY153)  DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND  INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN  |   DIFFERENTIAL INHIBITION, TRANSFERASE, CDK2, ATP-BINDING, CELL CYCLE, CELL DIVISION, POLYMORPHISM, PHOSPHORYLATION, NUCLEOTIDE-BINDING, SERINE/THREONINE-PROTEIN, KINASE, MITOSIS, CYCLIN 
2c5n:C    (GLY16) to   (GLY153)  DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND  INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN  |   DIFFERENTIAL INHIBITION, TRANSFERASE, CDK2, ATP-BINDING, CELL CYCLE, CELL DIVISION, POLYMORPHISM, PHOSPHORYLATION, NUCLEOTIDE-BINDING, SERINE/THREONINE-PROTEIN, KINASE, MITOSIS, CYCLIN 
2c5x:C    (GLY16) to   (GLY153)  DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN  |   TRANSFERASE/INHIBITOR, INHIBITION, ACTIVE, INACTIVE, CDK2, CELL CYCLE, CELL DIVISION, KINASE, MITOSIS, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE, ATP-BINDING, COMPLEX (TRANSFERASE/INHIBITOR) 
2pzy:C    (GLY76) to   (THR215)  STRUCTURE OF MK2 COMPLEXED WITH COMPOUND 76  |   MK2, PROTEIN KINASE, TRANSFERASE 
4ib5:A    (GLU55) to   (PHE181)  STRUCTURE OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT IN COMPLEX WITH A CK2BETA-COMPETITIVE CYCLIC PEPTIDE  |   PROTEIN KINASE FOLD, PROTEIN PHOSPHORYLATION, BINDING OF CK2BETA, PHOSPHORYLATION, NUCLEUS, TRANSFERASE 
4ib5:B    (SER51) to   (PHE181)  STRUCTURE OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT IN COMPLEX WITH A CK2BETA-COMPETITIVE CYCLIC PEPTIDE  |   PROTEIN KINASE FOLD, PROTEIN PHOSPHORYLATION, BINDING OF CK2BETA, PHOSPHORYLATION, NUCLEUS, TRANSFERASE 
4ib5:C    (SER51) to   (PHE181)  STRUCTURE OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT IN COMPLEX WITH A CK2BETA-COMPETITIVE CYCLIC PEPTIDE  |   PROTEIN KINASE FOLD, PROTEIN PHOSPHORYLATION, BINDING OF CK2BETA, PHOSPHORYLATION, NUCLEUS, TRANSFERASE 
4idt:A   (GLY412) to   (LEU541)  CRYSTAL STRUCTURE OF NIK WITH 11-BROMO-5,6,7,8-TETRAHYDROPYRIMIDO[4', 5':3,4]CYCLOHEPTA[1,2-B]INDOL-2-AMINE (T28)  |   NIK, NUCLEAR FACTOR (NF)-KB, P100 PROCESSING, 2-AMINOPYRIMIDINE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4idv:C   (HIS415) to   (PRO543)  CRYSTAL STRUCTURE OF NIK WITH COMPOUND 4-{3-[2-AMINO-5-(2- METHOXYETHOXY)PYRIMIDIN-4-YL]-1H-INDOL-5-YL}-2-METHYLBUT-3-YN-2-OL (13V)  |   NIK, NUCLEAR FACTOR (NF)-KB, P100 PROCESSING, 2-AMINOPYRIMIDINE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3fyj:X    (ASN75) to   (GLU213)  CRYSTAL STRUCTURE OF AN OPTIMZIED BENZOTHIOPHENE INHIBITOR BOUND TO MAPKAP KINASE-2 (MK-2)  |   MK-2, MK2, MAPKAP-2, SER/THR KINASE, MAP KINASE, ALTERNATIVE SPLICING, ATP-BINDING, KINASE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, POLYMORPHISM, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE 
4xne:A    (GLY35) to   (VAL171)  CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH AN INHIBITOR  |   SERINE THREONINE KINASE INHIBITOR, TRANSFERASE 
2cdz:A   (GLY333) to   (SER466)  CRYSTAL STRUCTURE OF THE HUMAN P21-ACTIVATED KINASE 4 IN COMPLEX WITH CGP74514A  |   TRANSFERASE, PROTEIN KINASE, STE20, PAK4, ATP-BINDING 
4xoy:A    (GLY35) to   (VAL171)  CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH AN INHIBITOR  |   SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE 
4xoz:A    (GLY35) to   (VAL171)  CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH AN INHIBITOR  |   SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE 
4xp0:A    (GLY35) to   (VAL171)  CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH AN INHIBITOR  |   SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE 
4xp3:A    (GLY35) to   (VAL171)  CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH AN INHIBITOR  |   SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE 
2qg5:B    (GLY40) to   (ARG175)  CRYPTOSPORIDIUM PARVUM CALCIUM DEPENDENT PROTEIN KINASE CGD7_1840  |   MALARIA, CALCIUM DEPENDENT KINASE, SGC, STRUCTURAL GENOMICS CONSORTIUM, TRANSFERASE 
4xrj:A    (GLY35) to   (VAL171)  CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH AN INHIBITOR  |   SERINE THREONINE KINASE INHIBITOR, APOPTOSIS 
4xrl:A    (GLY35) to   (VAL171)  CRYSTAL STRUCTURE AT ROOM TEMPERATURE OF ERK2 IN COMPLEX WITH AN INHIBITOR  |   SERINE THREONINE KINASE INHIBITOR, TRANSFERASE 
2qkr:A    (VAL36) to   (PHE169)  CRYPTOSPORIDIUM PARVUM CYCLIN-DEPENDENT KINASE CGD5_2510 WITH INDIRUBIN 3'-MONOXIME BOUND  |   CP-SPECIFIC CYCLIN-DEPENDENT KINASE, MALARIA, CRYPTOSPORIDIUM PARVUM, STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC, TRANSFERASE 
3gb2:A    (VAL69) to   (GLN206)  GSK3BETA INHIBITOR COMPLEX  |   PROTEIN KINASE, INHIBITOR, COMPLEX, ATP-BINDING, KINASE, NUCLEOTIDE- BINDING, PHOSPHOPROTEIN, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE, WNT SIGNALING PATHWAY, CDM 
1pjk:A    (SER51) to   (TYR182)  CRYSTAL STRUCTURE OF A C-TERMINAL DELETION MUTANT OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT  |   EUKARYOTIC PROTEIN KINASE FOLD, TRANSFERASE 
4iva:A   (GLY861) to  (GLN1003)  JAK2 KINASE (JH1 DOMAIN) IN COMPLEX WITH THE INHIBITOR TRANS-4-[(8AS)- 2-[(1R)-1-HYDROXYETHYL]IMIDAZO[4,5-D]PYRROLO[2,3-B]PYRIDIN-1(8AH)- YL]CYCLOHEXANECARBONITRILE  |   PROTEIN KINASE, PHOSPHOTRANSFER, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4ivb:A   (GLY887) to  (THR1030)  JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH THE INHIBITOR TRANS-4-{2- [(1R)-1-HYDROXYETHYL]IMIDAZO[4,5-D]PYRROLO[2,3-B]PYRIDIN-1(6H)- YL}CYCLOHEXANECARBONITRILE  |   PROTEIN KINASE, PHOSPHOTRANSFER, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4iz5:A    (GLY37) to   (VAL173)  STRUCTURE OF THE COMPLEX BETWEEN ERK2 PHOSPHOMIMETIC MUTANT AND PEA-15  |   MAP KINASE, DEATH EFFECTOR DOMAIN, TRANSFERASE 
4iz5:B    (GLY37) to   (VAL173)  STRUCTURE OF THE COMPLEX BETWEEN ERK2 PHOSPHOMIMETIC MUTANT AND PEA-15  |   MAP KINASE, DEATH EFFECTOR DOMAIN, TRANSFERASE 
4iz5:C    (GLY37) to   (VAL173)  STRUCTURE OF THE COMPLEX BETWEEN ERK2 PHOSPHOMIMETIC MUTANT AND PEA-15  |   MAP KINASE, DEATH EFFECTOR DOMAIN, TRANSFERASE 
4iz5:D    (GLY37) to   (VAL173)  STRUCTURE OF THE COMPLEX BETWEEN ERK2 PHOSPHOMIMETIC MUTANT AND PEA-15  |   MAP KINASE, DEATH EFFECTOR DOMAIN, TRANSFERASE 
4iz7:C    (GLY37) to   (VAL173)  STRUCTURE OF NON-PHOSPHORYLATED ERK2 BOUND TO THE PEA-15 DEATH EFFECTOR DOMAIN  |   MAP KINASE, DEATH EFFECTOR DOMAIN, TRANSFERASE 
4iz7:A    (GLY37) to   (VAL173)  STRUCTURE OF NON-PHOSPHORYLATED ERK2 BOUND TO THE PEA-15 DEATH EFFECTOR DOMAIN  |   MAP KINASE, DEATH EFFECTOR DOMAIN, TRANSFERASE 
4iza:A    (GLY37) to   (VAL173)  STRUCTURE OF DUALLY PHOSPHORYLATED ERK2 BOUND TO THE PEA-15 DEATH EFFECTOR DOMAIN  |   MAP KINASE, DEATH EFFECTOR DOMAIN, TRANSFERASE 
4iza:C    (GLY37) to   (VAL173)  STRUCTURE OF DUALLY PHOSPHORYLATED ERK2 BOUND TO THE PEA-15 DEATH EFFECTOR DOMAIN  |   MAP KINASE, DEATH EFFECTOR DOMAIN, TRANSFERASE 
3gok:A    (LEU79) to   (THR215)  BINDING SITE MAPPING OF PROTEIN LIGANDS  |   MK2, MAPKAP KINASE 2, ISOTOPE LABELLING, INSECT CELL EXPRESSION, ATP- BINDING, KINASE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE 
3gok:B    (LEU79) to   (THR215)  BINDING SITE MAPPING OF PROTEIN LIGANDS  |   MK2, MAPKAP KINASE 2, ISOTOPE LABELLING, INSECT CELL EXPRESSION, ATP- BINDING, KINASE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE 
3gok:C    (LEU79) to   (THR215)  BINDING SITE MAPPING OF PROTEIN LIGANDS  |   MK2, MAPKAP KINASE 2, ISOTOPE LABELLING, INSECT CELL EXPRESSION, ATP- BINDING, KINASE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE 
3gok:D    (LEU79) to   (THR214)  BINDING SITE MAPPING OF PROTEIN LIGANDS  |   MK2, MAPKAP KINASE 2, ISOTOPE LABELLING, INSECT CELL EXPRESSION, ATP- BINDING, KINASE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE 
3gok:E    (LEU79) to   (THR215)  BINDING SITE MAPPING OF PROTEIN LIGANDS  |   MK2, MAPKAP KINASE 2, ISOTOPE LABELLING, INSECT CELL EXPRESSION, ATP- BINDING, KINASE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE 
3gok:F    (LEU79) to   (THR215)  BINDING SITE MAPPING OF PROTEIN LIGANDS  |   MK2, MAPKAP KINASE 2, ISOTOPE LABELLING, INSECT CELL EXPRESSION, ATP- BINDING, KINASE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE 
3gok:G    (LEU79) to   (THR215)  BINDING SITE MAPPING OF PROTEIN LIGANDS  |   MK2, MAPKAP KINASE 2, ISOTOPE LABELLING, INSECT CELL EXPRESSION, ATP- BINDING, KINASE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE 
3gok:H    (LEU79) to   (THR215)  BINDING SITE MAPPING OF PROTEIN LIGANDS  |   MK2, MAPKAP KINASE 2, ISOTOPE LABELLING, INSECT CELL EXPRESSION, ATP- BINDING, KINASE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE 
3gok:I    (LEU79) to   (THR215)  BINDING SITE MAPPING OF PROTEIN LIGANDS  |   MK2, MAPKAP KINASE 2, ISOTOPE LABELLING, INSECT CELL EXPRESSION, ATP- BINDING, KINASE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE 
3gok:J    (LEU79) to   (THR214)  BINDING SITE MAPPING OF PROTEIN LIGANDS  |   MK2, MAPKAP KINASE 2, ISOTOPE LABELLING, INSECT CELL EXPRESSION, ATP- BINDING, KINASE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE 
3gok:K    (LEU79) to   (THR215)  BINDING SITE MAPPING OF PROTEIN LIGANDS  |   MK2, MAPKAP KINASE 2, ISOTOPE LABELLING, INSECT CELL EXPRESSION, ATP- BINDING, KINASE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE 
3gok:L    (LEU79) to   (THR215)  BINDING SITE MAPPING OF PROTEIN LIGANDS  |   MK2, MAPKAP KINASE 2, ISOTOPE LABELLING, INSECT CELL EXPRESSION, ATP- BINDING, KINASE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE 
1pyx:A    (GLY68) to   (GLN206)  GSK-3 BETA COMPLEXED WITH AMP-PNP  |   KINASE, INSULIN PATHWAY, TRANSFERASE 
4y73:A   (GLY198) to   (SER336)  CRYSTAL STRUCTURE OF IRAK4 KINASE DOMAIN WITH INHIBITOR  |   KINASE, INHIBITOR 
4y73:C   (GLY198) to   (SER336)  CRYSTAL STRUCTURE OF IRAK4 KINASE DOMAIN WITH INHIBITOR  |   KINASE, INHIBITOR 
4y73:D   (GLY198) to   (SER336)  CRYSTAL STRUCTURE OF IRAK4 KINASE DOMAIN WITH INHIBITOR  |   KINASE, INHIBITOR 
3tei:A    (TYR36) to   (ALA174)  CRYSTAL STRUCTURE OF HUMAN ERK2 COMPLEXED WITH A MAPK DOCKING PEPTIDE  |   TRANSFERASE 
2r7i:A    (SER51) to   (PHE181)  CRYSTAL STRUCTURE OF CATALYTIC SUBUNIT OF PROTEIN KINASE CK2  |   CATALYTIC SUBUNIT, KINASE, ATP-BINDING, NUCLEOTIDE-BINDING, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE, WNT SIGNALING PATHWAY 
2r7i:B    (TYR50) to   (PHE181)  CRYSTAL STRUCTURE OF CATALYTIC SUBUNIT OF PROTEIN KINASE CK2  |   CATALYTIC SUBUNIT, KINASE, ATP-BINDING, NUCLEOTIDE-BINDING, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE, WNT SIGNALING PATHWAY 
2r7i:C    (GLU52) to   (PHE181)  CRYSTAL STRUCTURE OF CATALYTIC SUBUNIT OF PROTEIN KINASE CK2  |   CATALYTIC SUBUNIT, KINASE, ATP-BINDING, NUCLEOTIDE-BINDING, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE, WNT SIGNALING PATHWAY 
2r7i:D    (SER51) to   (PHE181)  CRYSTAL STRUCTURE OF CATALYTIC SUBUNIT OF PROTEIN KINASE CK2  |   CATALYTIC SUBUNIT, KINASE, ATP-BINDING, NUCLEOTIDE-BINDING, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE, WNT SIGNALING PATHWAY 
1q3d:A    (GLY68) to   (GLN206)  GSK-3 BETA COMPLEXED WITH STAUROSPORINE  |   KINASE, INSULIN PATHWAY, TRANSFERASE 
4y83:A   (PHE149) to   (GLN276)  CRYSTAL STRUCTURE OF COT KINASE DOMAIN IN COMPLEX WITH 5-(2-AMINO-5- (QUINOLIN-3-YL)PYRIDIN-3-YL)-1,3,4-OXADIAZOLE-2(3H)-THIONE  |   COT, TPL-2, MAP3K8, KINASE, INHIBITOR, COMPLEX, TRANSFERASE 
4y83:B   (PHE149) to   (MET277)  CRYSTAL STRUCTURE OF COT KINASE DOMAIN IN COMPLEX WITH 5-(2-AMINO-5- (QUINOLIN-3-YL)PYRIDIN-3-YL)-1,3,4-OXADIAZOLE-2(3H)-THIONE  |   COT, TPL-2, MAP3K8, KINASE, INHIBITOR, COMPLEX, TRANSFERASE 
3tjc:A   (PHE860) to  (GLN1003)  CO-CRYSTAL STRUCTURE OF JAK2 WITH THIENOPYRIDINE 8  |   JAK2, KINASE, INHIBITOR, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3tjc:B   (GLY861) to  (GLN1003)  CO-CRYSTAL STRUCTURE OF JAK2 WITH THIENOPYRIDINE 8  |   JAK2, KINASE, INHIBITOR, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3tjd:A   (GLY861) to  (GLN1003)  CO-CRYSTAL STRUCTURE OF JAK2 WITH THIENOPYRIDINE 19  |   JAK2, KINASE, INHIBITOR, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3tjd:B   (GLY861) to  (GLN1003)  CO-CRYSTAL STRUCTURE OF JAK2 WITH THIENOPYRIDINE 19  |   JAK2, KINASE, INHIBITOR, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3tnh:A    (GLY31) to   (ALA173)  CDK9/CYCLIN T IN COMPLEX WITH CAN508  |   KINASE, CYCLIN, PHOSPHTRANSFER, CYCLIN T, PHOSPHORYLATED ON THREONINE 186, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3tni:A    (GLU32) to   (ALA173)  STRUCTURE OF CDK9/CYCLIN T F241L  |   CYCLIN DEPENDENT KINASE, KINASE ,CYCLIN, PHOSPHOTRANSFER, CDK-CYCLIN COMPLEX, PHOSPHORYLATED ON THREONINE 186, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4jg8:A   (SER434) to   (LEU568)  STRUCTURE OF RSK2 T493M CTD MUTANT BOUND TO 2-CYANO-N-(1-HYDROXY-2- METHYLPROPAN-2-YL)-3-(3-(3,4,5-TRIMETHOXYPHENYL)-1H-INDAZOL-5-YL) ACRYLAMIDE  |   PROTEIN KINASE, PHOSPHORYLATION, COVALENT INHIBITOR, TRANSFERASE- TRANSFERASE INHIBITOR COMPLEX 
4ji9:A   (PHE860) to  (GLN1003)  JAK2 KINASE (JH1 DOMAIN) IN COMPLEX WITH TG101209  |   PROTEIN KINASE, PHOSPHO-TRANSFER CATALYST, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4ji9:B   (GLY861) to  (GLN1003)  JAK2 KINASE (JH1 DOMAIN) IN COMPLEX WITH TG101209  |   PROTEIN KINASE, PHOSPHO-TRANSFER CATALYST, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
1ql6:A    (SER31) to   (GLN173)  THE CATALYTIC MECHANISM OF PHOSPHORYLASE KINASE PROBED BY MUTATIONAL STUDIES  |   KINASE (GLYCOGEN METABOLISM), GLYCOGEN METABOLISM, TRANSFERASE, SERINE/THREONINE-PROTEIN, KINASE, ATP-BINDING, CALMODULIN-BINDING 
3h30:B    (SER51) to   (PHE181)  CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF HUMAN PROTEIN KINASE CK2 WITH 5,6-DICHLORO-1-BETA-D- RIBOFURANOSYLBENZIMIDAZOLE  |   PROTEIN KINASE CK2, CASEIN KINASE 2, CASEIN KINASE II, ATP- BINDING, KINASE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE, WNT SIGNALING PATHWAY 
1f0q:A    (GLU55) to   (PHE181)  CRYSTAL STRUCTURE OF THE ALPHA SUBUNIT OF PROTEIN KINASE CK2 IN COMPLEX WITH THE NUCLEOTIDE COMPETITIVE INHIBITOR EMODIN  |   PROTEIN KINASE-INHIBITOR COMPLEX, TRANSFERASE 
4ylj:A   (GLN172) to   (GLN313)  CRYSTAL STRUCTURE OF DYRK1A IN COMPLEX WITH 10-IODO-SUBSTITUTED 11H- INDOLO[3,2-C]QUINOLINE-6-CARBOXYLIC ACID INHIBITOR 5J  |   HALOGEN, INHIBITOR, STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4ylj:B   (GLY171) to   (GLN313)  CRYSTAL STRUCTURE OF DYRK1A IN COMPLEX WITH 10-IODO-SUBSTITUTED 11H- INDOLO[3,2-C]QUINOLINE-6-CARBOXYLIC ACID INHIBITOR 5J  |   HALOGEN, INHIBITOR, STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4ylj:C   (GLY171) to   (GLN313)  CRYSTAL STRUCTURE OF DYRK1A IN COMPLEX WITH 10-IODO-SUBSTITUTED 11H- INDOLO[3,2-C]QUINOLINE-6-CARBOXYLIC ACID INHIBITOR 5J  |   HALOGEN, INHIBITOR, STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4ylj:D   (GLY171) to   (GLN313)  CRYSTAL STRUCTURE OF DYRK1A IN COMPLEX WITH 10-IODO-SUBSTITUTED 11H- INDOLO[3,2-C]QUINOLINE-6-CARBOXYLIC ACID INHIBITOR 5J  |   HALOGEN, INHIBITOR, STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4ylk:A   (GLY171) to   (GLN313)  CRYSTAL STRUCTURE OF DYRK1A IN COMPLEX WITH 10-CHLORO-SUBSTITUTED 11H- INDOLO[3,2-C]QUINOLONE-6-CARBOXYLIC ACID INHIBITOR 5S  |   HALOGEN, INHIBITOR, STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4yll:A   (GLN172) to   (GLN313)  CRYSTAL STRUCTURE OF DYRK1AA IN COMPLEX WITH 10-BROMO-SUBSTITUTED 11H- INDOLO[3,2-C]QUINOLONE-6-CARBOXYLIC ACID INHIBITOR 5T  |   HALOGEN, INHIBITOR, STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
1r0e:B    (GLY68) to   (GLN206)  GLYCOGEN SYNTHASE KINASE-3 BETA IN COMPLEX WITH 3-INDOLYL-4- ARYLMALEIMIDE INHIBITOR  |   SER/THR PROTEIN KINASE, TRANSFERASE 
3u87:A    (SER51) to   (PHE181)  STRUCTURE OF A CHIMERIC CONSTRUCT OF HUMAN CK2ALPHA AND HUMAN CK2ALPHA' IN COMPLEX WITH A NON-HYDROLYSABLE ATP-ANALOGUE  |   PROTEIN KINASE CK2 CASEIN KINASE 2, PROTEIN KINASE FOLD, EUKARYOTIC PROTEIN KINASE, TRANSFERASE 
3u87:B    (SER51) to   (PHE181)  STRUCTURE OF A CHIMERIC CONSTRUCT OF HUMAN CK2ALPHA AND HUMAN CK2ALPHA' IN COMPLEX WITH A NON-HYDROLYSABLE ATP-ANALOGUE  |   PROTEIN KINASE CK2 CASEIN KINASE 2, PROTEIN KINASE FOLD, EUKARYOTIC PROTEIN KINASE, TRANSFERASE 
3u8w:A    (GLY36) to   (THR175)  CRYSTAL STRUCTURE OF P38A MITOGEN-ACTIVATED PROTEIN KINASE IN COMPLEX WITH A TRIAZOLOPYRIDAZINONE INHIBITOR  |   SERINE/THREONINE PROTEIN KINASE, TRANSFERASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
2uzd:C    (GLY16) to   (ALA151)  CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR  |   TRANSFERASE, ATP-BINDING, PHOSPHORYLATION, CDK2, KINASE, CYCLIN, MITOSIS, CELL CYCLE, CELL DIVISION, NUCLEOTIDE- BINDING, SERINE/THREONINE-PROTEIN KINASE, THIAZOLIDINONE LIGAND 
4yo6:C   (GLY198) to   (SER336)  IRAK4-INHIBITOR CO-STRUCTURE  |   KINASE, PHOSPHATASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4yo6:D   (GLY198) to   (SER336)  IRAK4-INHIBITOR CO-STRUCTURE  |   KINASE, PHOSPHATASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4yp8:A   (GLY198) to   (SER336)  IRAK4-INHIBITOR CO-STRUCTURE  |   KINASE, PHOSPHATASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4yp8:C   (GLY198) to   (SER336)  IRAK4-INHIBITOR CO-STRUCTURE  |   KINASE, PHOSPHATASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4yp8:D   (GLY198) to   (SER336)  IRAK4-INHIBITOR CO-STRUCTURE  |   KINASE, PHOSPHATASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
2v22:A    (GLY16) to   (GLY153)  REPLACE: A STRATEGY FOR ITERATIVE DESIGN OF CYCLIN BINDING GROOVE INHIBITORS  |   POLYMORPHISM, CYCLIN GROOVE, CELL DIVISION, CDK2, KINASE, CYCLIN, ACTIVE, MITOSIS, INHIBITION, PHOSPHORYLATION, NUCLEOTIDE-BINDING, SERINE/THREONINE-PROTEIN KINASE, CELL CYCLE, NONPEPTIDE, TRANSFERASE, ATP-BINDING 
1fin:C    (GLY16) to   (GLY153)  CYCLIN A-CYCLIN-DEPENDENT KINASE 2 COMPLEX  |   COMPLEX (TRANSFERASE/CYCLIN), CYCLIN, CDK, PHOSPHORYLATION 
2erk:A    (MET36) to   (ASP175)  PHOSPHORYLATED MAP KINASE ERK2  |   PHOSPHOTRANSFERASE, KINASE, SERINE/THREONINE-PROTEIN KINASE 
4ytf:A   (GLY861) to  (GLN1003)  DISCOVERY OF VX-509 (DECERNOTINIB): A POTENT AND SELECTIVE JANUS KINASE (JAK) 3 INHIBITOR FOR THE TREATMENT OF AUTOIMMUNE DISEASES  |   JANUS KINASE, KINASE, INHIBITOR, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
1fq1:B    (GLY16) to   (PHE152)  CRYSTAL STRUCTURE OF KINASE ASSOCIATED PHOSPHATASE (KAP) IN COMPLEX WITH PHOSPHO-CDK2  |   PHOSPHO-PROTEIN/PROTEIN COMPLEX, HYDROLASE/TRANSFERASE COMPLEX 
2v7o:A    (PHE25) to   (GLN165)  CRYSTAL STRUCTURE OF HUMAN CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE II GAMMA  |   KINASE, S/T KINASE, TRANSFERASE, ATP-BINDING, SERINE/THREONINE-PROTEIN KINASE, NUCLEOTIDE-BINDING, PHOSPHORYLATION, CALMODULIN-BINDING 
4k6z:A   (LEU891) to  (THR1030)  THE JAK1 KINASE DOMAIN IN COMPLEX WITH COMPOUND 37  |   KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4k77:A   (GLY887) to  (THR1030)  JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 6  |   PROTEIN KINASE, PHOSPHOTRANSFER, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
1fvv:C    (GLY16) to   (GLY153)  THE STRUCTURE OF CDK2/CYCLIN A IN COMPLEX WITH AN OXINDOLE INHIBITOR  |   CYCLIN-DEPENDENT KINASE, CYCLIN A, TRANSFERASE, CELL CYCLE 
2f49:A    (GLY25) to   (ILE161)  CRYSTAL STRUCTURE OF FUS3 IN COMPLEX WITH A STE5 PEPTIDE  |   PROTEIN-PETIDE COMPLEX, TRANSFERASE 
2f57:A   (GLY461) to   (SER594)  CRYSTAL STRUCTURE OF THE HUMAN P21-ACTIVATED KINASE 5  |   PAK5, KINASE DOMAINS, GROUPII PAKS, STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC, TRANSFERASE 
2fa2:B    (GLY25) to   (ILE161)  CRYSTAL STRUCTURE OF FUS3 WITHOUT A PEPTIDE FROM STE5  |   MAP KINASE, TRANSFERASE 
1gng:A    (GLY68) to   (GLN206)  GLYCOGEN SYNTHASE KINASE-3 BETA (GSK3) COMPLEX WITH FRATTIDE PEPTIDE  |   TRANSFERASE, PROTEIN KINASE, GSK3/FRATTIDE COMPLEX, PHOSPHORYLATED, ACTIVE 
2fys:B    (MET36) to   (ASP173)  CRYSTAL STRUCTURE OF ERK2 COMPLEX WITH KIM PEPTIDE DERIVED FROM MKP3  |   MAP KINASE, MKP3, KIM, TRANSFERASE 
2fys:A    (GLY35) to   (ALA172)  CRYSTAL STRUCTURE OF ERK2 COMPLEX WITH KIM PEPTIDE DERIVED FROM MKP3  |   MAP KINASE, MKP3, KIM, TRANSFERASE 
2vn9:A    (SER26) to   (GLN165)  CRYSTAL STRUCTURE OF HUMAN CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II DELTA ISOFORM 1, CAMKD  |   SERINE/THREONINE-PROTEIN KINASE, SERINE-THREONINE KINASE, CELLULAR DIFFERENTIATION, VASCULAR SMOOTH MUSCLE, KINASE, TRANSFERASE, ATP-BINDING, PHOSPHOPROTEIN, CALMODULIN-BINDING, NUCLEOTIDE-BINDING 
2vn9:B    (SER26) to   (GLN165)  CRYSTAL STRUCTURE OF HUMAN CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II DELTA ISOFORM 1, CAMKD  |   SERINE/THREONINE-PROTEIN KINASE, SERINE-THREONINE KINASE, CELLULAR DIFFERENTIATION, VASCULAR SMOOTH MUSCLE, KINASE, TRANSFERASE, ATP-BINDING, PHOSPHOPROTEIN, CALMODULIN-BINDING, NUCLEOTIDE-BINDING 
1gol:A    (GLY35) to   (ALA172)  COORDINATES OF RAT MAP KINASE ERK2 WITH AN ARGININE MUTATION AT POSITION 52  |   TRANSFERASE, SERINE/THREONINE-PROTEIN KINASE, ATP-BINDING, CELL CYCLE, PHOSPHORYLATION 
4krc:A    (THR20) to   (GLY159)  CRYSTAL STRUCTURE OF PHO85-PCL10-ATP-GAMMA-S COMPLEX  |   GLYCOGEN SYNTHESIS, GLYCOGEN SYNTHESIS REGULATION, TRANSFERASE- SIGNALING PROTEIN COMPLEX 
4ks7:A   (ILE420) to   (SER552)  PAK6 KINASE DOMAIN IN COMPLEX WITH PF-3758309  |   PROTEIN KINASE, PHOSPHOTRANSFER, PHOSPHORYLATION, TRANSFERASE- TRANSFERASE INHIBITOR COMPLEX 
4ks8:A   (GLY419) to   (SER552)  PAK6 KINASE DOMAIN IN COMPLEX WITH SUNITINIB  |   PROTEIN KINASE, PHOSPHOTRANSFER, PHOSPHORYLATION, TRANSFERASE- TRANSFERASE INHIBITOR COMPLEX 
4zim:A   (GLY861) to  (GLN1003)  CRYSTAL STRUCTURE OF JANUS KINASE 2 IN COMPLEX WITH A 9H-CARBAZOLE-1- CARBOXAMIDE INHIBITOR  |   KINASE, TRANSFERASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4zim:B   (GLY861) to  (GLN1003)  CRYSTAL STRUCTURE OF JANUS KINASE 2 IN COMPLEX WITH A 9H-CARBAZOLE-1- CARBOXAMIDE INHIBITOR  |   KINASE, TRANSFERASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4kwp:A    (GLU55) to   (PHE181)  CRYSTAL STRUCTURE OF HUMAN CK2-ALPHA IN COMPLEX WITH A BENZIMIDAZOLE INHIBITOR (K164) AT 1.25 A RESOLUTION  |   KINASE, PHOSPHORYLATION, SMALL MOLECULE INHIBITOR, TRANSFERASE- TRANSFERASE INHIBITOR COMPLEX 
3i5z:A    (GLY35) to   (VAL171)  CRYSTAL STRUCTURE OF ERK2 BOUND TO (S)-N-(2-HYDROXY-1-PHENYLETHYL)-4- (5-METHYL-2-(PHENYLAMINO)PYRIMIDIN-4-YL)-1H-PYRROLE-2-CARBOXAMIDE  |   KINASE, INHIBITOR, ATP-BINDING, CELL CYCLE, HOST-VIRUS INTERACTION, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE 
4zji:A   (GLY282) to   (ILE414)  PAK1 IN COMPLEX WITH 2-CHLORO-5-ETHYL-8-FLUORO-11-(4-METHYLPIPERAZIN- 1-YL)-DIBENZODIAZEPINE  |   INHIBITOR, KINASE, PAK1, ALLOSTERIC, TRANSFERASE 
4zji:B   (GLY282) to   (ILE414)  PAK1 IN COMPLEX WITH 2-CHLORO-5-ETHYL-8-FLUORO-11-(4-METHYLPIPERAZIN- 1-YL)-DIBENZODIAZEPINE  |   INHIBITOR, KINASE, PAK1, ALLOSTERIC, TRANSFERASE 
4zjj:A   (GLY282) to   (ILE414)  PAK1 IN COMPLEX WITH (S)-N-(TERT-BUTYL)-3-((2-CHLORO-5-ETHYL-8-FLUORO- DIBENZODIAZEPIN-11-YL)AMINO)PYRROLIDINE-1-CARBOXAMIDE  |   PAK1, INHIBITOR, KINASE, ALLOSTERIC, TRANSFERASE 
1h26:A    (VAL17) to   (ALA151)  CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P53  |   CELL CYCLE, PROTEIN KINASE, CYCLIN, CDK2, RECRUITMENT, PEPTIDE SPECIFICITY 
1h27:A    (VAL17) to   (ALA151)  CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P27  |   CELL CYCLE, PROTEIN KINASE, CYCLIN, CDK2, RECRUITMENT, PEPTIDE SPECIFICITY, SERINE/THREONINE-PROTEIN KINASE, ATP-BINDING, CELL DIVISION, MITOSIS, PHOSPHORYLATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
1h4l:B    (GLY16) to   (GLY152)  STRUCTURE AND REGULATION OF THE CDK5-P25(NCK5A) COMPLEX  |   KINASE/KINASE ACTIVATOR, COMPLEX(CYCLINS/CDK), CYCLINS, CYCLIN-DEPENDENT KINASES, CDK5, P35, P25, TRANSFERASE, ATP-BINDING, CELL CYCLE, CELL DIVISION, PHOSPHORYLATION 
2w1i:A   (GLY861) to  (LEU1001)  STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR  |   CHROMOSOMAL REARRANGEMENT, NUCLEOTIDE-BINDING, TYROSINE-PROTEIN KINASE, PROTO-ONCOGENE, PHOSPHOPROTEIN, DISEASE MUTATION, SH2 DOMAIN, TRANSFERASE, ATP-BINDING, POLYMORPHISM, KINASE, CANCER, AURORA, MEMBRANE, INHIBITOR 
2w1i:B   (GLY861) to  (GLN1003)  STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR  |   CHROMOSOMAL REARRANGEMENT, NUCLEOTIDE-BINDING, TYROSINE-PROTEIN KINASE, PROTO-ONCOGENE, PHOSPHOPROTEIN, DISEASE MUTATION, SH2 DOMAIN, TRANSFERASE, ATP-BINDING, POLYMORPHISM, KINASE, CANCER, AURORA, MEMBRANE, INHIBITOR 
4ztm:C   (GLY198) to   (SER336)  IRAK4-INHIBITOR CO-STRUCTURE  |   KINASE, PHOSPHATASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4ztm:D   (GLY198) to   (SER336)  IRAK4-INHIBITOR CO-STRUCTURE  |   KINASE, PHOSPHATASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4ztn:C   (VAL199) to   (SER336)  IRAK4-INHIBITOR CO-STRUCTURE  |   KINASE, PHOSPHATASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4ztn:D   (GLY198) to   (SER336)  IRAK4-INHIBITOR CO-STRUCTURE  |   KINASE, PHOSPHATASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3io7:A   (GLY861) to  (GLN1003)  2-AMINOPYRAZOLO[1,5-A]PYRIMIDINES AS POTENT AND SELECTIVE INHIBITORS OF JAK2  |   KINASE, INHIBITOR, JAK2, JANUS KINASE, ATP-BINDING, CHROMOSOMAL REARRANGEMENT, DISEASE MUTATION, MEMBRANE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, POLYMORPHISM, PROTO- ONCOGENE, SH2 DOMAIN, TRANSFERASE, TYROSINE-PROTEIN KINASE 
4zxt:A    (GLY37) to   (VAL173)  COMPLEX OF ERK2 WITH CATECHOL  |   CATECHOL COMPLEX, MITOGEN-ACTIVATED PROTEIN KINASE, SIGNAL-REGULATED KINASE, TRANSFERASE 
2wel:A    (SER26) to   (GLN165)  CRYSTAL STRUCTURE OF SU6656-BOUND CALCIUM/CALMODULIN- DEPENDENT PROTEIN KINASE II DELTA IN COMPLEX WITH CALMODULIN  |   CELLULAR DIFFERENTIATION, SERINE/THREONINE-PROTEIN KINASE, PHOSPHOPROTEIN, CALMODULIN-BINDING, CALMODULIN BINDING, KINASE, TRANSFERASE, ATP-BINDING, NUCLEOTIDE-BINDING, VASCULAR SMOOTH MUSCLE, SERINE-THREONINE KINASE 
4ll0:A   (LYS737) to   (LEU862)  EGFR L858R/T790M IN COMPLEX WITH PD168393  |   KINASE, PD168393, 34-JAB, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
2wfy:A    (GLY16) to   (GLY153)  TRUNCATION AND OPTIMISATION OF PEPTIDE INHIBITORS OF CDK2, CYCLIN A THROUGH STRUCTURE GUIDED DESIGN  |   CDK2, KINASE, CYCLIN, ACTIVE, NUCLEUS, MITOSIS, SERINE/THREONINE-PROTEIN KINASE, CYTOPLASM, INHIBITION, CELL CYCLE, ATP-BINDING, CELL DIVISION, PHOSPHOPROTEIN, NUCLEOTIDE-BINDING, TRANSFERASE, POLYMORPHISM, BETA-PEPTIDE, CYCLIN GROOVE 
4zzm:A    (GLY37) to   (VAL173)  HUMAN ERK2 IN COMPLEX WITH AN IRREVERSIBLE INHIBITOR  |   TRANSFERASE 
4zzn:A    (GLY35) to   (VAL171)  HUMAN ERK2 IN COMPLEX WITH AN INHIBITOR  |   TRANSFERASE 
4zzo:A    (GLY37) to   (VAL173)  HUMAN ERK2 IN COMPLEX WITH AN IRREVERSIBLE INHIBITOR  |   TRANSFERASE 
2whb:A    (VAL17) to   (GLY153)  TRUNCATION AND OPTIMISATION OF PEPTIDE INHIBITORS OF CDK2, CYCLIN A THROUGH STRUCTURE GUIDED DESIGN  |   CDK2, KINASE, CYCLIN, ACTIVE, NUCLEUS, MITOSIS, SERINE/THREONINE-PROTEIN KINASE, CYTOPLASM, INHIBITION, CELL CYCLE, ATP-BINDING, CELL DIVISION, PHOSPHOPROTEIN, NUCLEOTIDE-BINDING, TRANSFERASE, POLYMORPHISM, BETA-PEPTIDE, CYCLIN GROOVE 
2wih:A    (GLY16) to   (GLY153)  STRUCTURE OF CDK2-CYCLIN A WITH PHA-848125  |   CELL CYCLE, ATP-BINDING, TRANSFERASE, POLYMORPHISM, PHOSPHORYLATION, NUCLEOTIDE-BINDING, CELL DIVISION, SERINE/THREONINE-PROTEIN 2 KINASE, PHOSPHOPROTEIN, SERINE/THREONINE-PROTEIN KINASE, MITOSIS 
2wih:C    (GLY16) to   (GLY153)  STRUCTURE OF CDK2-CYCLIN A WITH PHA-848125  |   CELL CYCLE, ATP-BINDING, TRANSFERASE, POLYMORPHISM, PHOSPHORYLATION, NUCLEOTIDE-BINDING, CELL DIVISION, SERINE/THREONINE-PROTEIN 2 KINASE, PHOSPHOPROTEIN, SERINE/THREONINE-PROTEIN KINASE, MITOSIS 
1u5q:B    (ALA41) to   (MET176)  CRYSTAL STRUCTURE OF THE TAO2 KINASE DOMAIN: ACTIVATION AND SPECIFITY OF A STE20P MAP3K  |   SERINE/THREONINE PROTEIN KINASE, TRANSFERASE 
3w8l:A    (GLU55) to   (PHE181)  CRYSTAL STRUCTURE OF HUMAN CK2 IN COMPLEX WITH INOSITOL HEXAKISPHOSPHATE  |   PROTEIN KINASE CK2, APOPTOSIS 
3w8l:B    (GLU55) to   (PHE181)  CRYSTAL STRUCTURE OF HUMAN CK2 IN COMPLEX WITH INOSITOL HEXAKISPHOSPHATE  |   PROTEIN KINASE CK2, APOPTOSIS 
1ung:A    (GLY16) to   (GLY152)  STRUCTURAL MECHANISM FOR THE INHIBITION OF CDK5-P25 BY ROSCOVITINE, ALOISINE AND INDIRUBIN.  |   CELL CYCLE, COMPLEX(KINASE/ACTIVATOR), INHIBITORS, NEURODEGENERATIVE DISEASES 
1ung:B    (THR17) to   (GLY152)  STRUCTURAL MECHANISM FOR THE INHIBITION OF CDK5-P25 BY ROSCOVITINE, ALOISINE AND INDIRUBIN.  |   CELL CYCLE, COMPLEX(KINASE/ACTIVATOR), INHIBITORS, NEURODEGENERATIVE DISEASES 
1unh:A    (GLY16) to   (GLY152)  STRUCTURAL MECHANISM FOR THE INHIBITION OF CDK5-P25 BY ROSCOVITINE, ALOISINE AND INDIRUBIN.  |   CELL CYCLE, NEURODEGENERATIVE DISEASES, INDIRUBIN 
1unh:B    (GLY16) to   (GLY152)  STRUCTURAL MECHANISM FOR THE INHIBITION OF CDK5-P25 BY ROSCOVITINE, ALOISINE AND INDIRUBIN.  |   CELL CYCLE, NEURODEGENERATIVE DISEASES, INDIRUBIN 
1unl:A    (GLY16) to   (GLY152)  STRUCTURAL MECHANISM FOR THE INHIBITION OF CD5-P25 FROM THE ROSCOVITINE, ALOISINE AND INDIRUBIN.  |   CYCLIN DEPENDENT KINASE, INHIBITOR, ATP-ANALOGUE, NEURODEGENERATIVE DISEASES 
1unl:B    (GLY16) to   (GLY152)  STRUCTURAL MECHANISM FOR THE INHIBITION OF CD5-P25 FROM THE ROSCOVITINE, ALOISINE AND INDIRUBIN.  |   CYCLIN DEPENDENT KINASE, INHIBITOR, ATP-ANALOGUE, NEURODEGENERATIVE DISEASES 
1urc:C    (GLY16) to   (GLY153)  CYCLIN A BINDING GROOVE INHIBITOR ACE-ARG-LYS-LEU-PHE-GLY  |   TRANSFERASE-INHIBITOR COMPLEX, INHIBITOR, LIGAND EXCHANGE, DRUG DESIGN, PEPTIDOMIMETICS 
4md8:E    (SER51) to   (PHE181)  CRYSTAL STRUCTURE OF FULL-LENGTH SYMMETRIC CK2 HOLOENZYME WITH MUTATED ALPHA SUBUNIT (F121E)  |   PROTEIN SERINE/THREONINE KINASE, TRANSFERASE 
4md8:F    (SER51) to   (PHE181)  CRYSTAL STRUCTURE OF FULL-LENGTH SYMMETRIC CK2 HOLOENZYME WITH MUTATED ALPHA SUBUNIT (F121E)  |   PROTEIN SERINE/THREONINE KINASE, TRANSFERASE 
3wi6:D    (LEU79) to   (THR215)  CRYSTAL STRUCTURE OF MAPKAP KINASE-2 (MK2) IN COMPLEX WITH NON- SELECTIVE INHIBITOR  |   GLY-RICH LOOP FORMED, ATP-BINDING, KINASE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE- TRANSFERASE INHIBITOR COMPLEX 
3wik:A    (GLU55) to   (PHE181)  CRYSTAL STRUCTURE OF THE CK2ALPHA/COMPOUND10 COMPLEX  |   TRANSFERASE 
1v0o:B    (GLY16) to   (PHE150)  STRUCTURE OF P. FALCIPARUM PFPK5-INDIRUBIN-5-SULPHONATE LIGAND COMPLEX  |   TRANSFERASE, SERINE/THREONINE-PROTEIN KINASE, ATP-BINDING, PHOSPHORYLATION, CDK 
5air:A    (GLY68) to   (GLN206)  STRUCTURAL ANALYSIS OF MOUSE GSK3BETA FUSED WITH LRP6 PEPTIDE.  |   TRANSFERASE, LRP6, GSK3 BETA 
1j91:A    (GLU55) to   (PHE181)  CRYSTAL STRUCTURE OF Z. MAYS CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE ATP-COMPETITIVE INHIBITOR 4,5,6,7- TETRABROMOBENZOTRIAZOLE  |   CK2, CASEIN KINASE 2, INHIBITORS, TETRABROMO-BENZOTRIAZOLE, TRANSFERASE 
1j91:B    (SER51) to   (PHE181)  CRYSTAL STRUCTURE OF Z. MAYS CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE ATP-COMPETITIVE INHIBITOR 4,5,6,7- TETRABROMOBENZOTRIAZOLE  |   CK2, CASEIN KINASE 2, INHIBITORS, TETRABROMO-BENZOTRIAZOLE, TRANSFERASE 
2xa4:A   (PHE860) to  (GLN1003)  INHIBITORS OF JAK2 KINASE DOMAIN  |   KINASE, MEMBRANE, TRANSFERASE, ATP-BINDING, PROTO-ONCOGENE, PHOSPHOPROTEIN 
2j0i:A   (GLY333) to   (SER466)  CRYSTAL STRUCTURE OF THE HUMAN P21-ACTIVATED KINASE 4  |   PROTEIN KINASE, PHOSPHORYLATION, NUCLEOTIDE-BINDING, PAK4, STE20, KINASE, TRANSFERASE, ATP-BINDING, ALTERNATIVE SPLICING, SERINE/THREONINE-PROTEIN KINASE 
4mwh:A    (GLU53) to   (PHE220)  CRYSTAL STRUCTURE OF SCCK2 ALPHA IN COMPLEX WITH ATP  |   PROTEIN KINASE, PROTEIN PHOSPHORYLATION, TRANSFERASE 
1jwh:B    (SER51) to   (PHE181)  CRYSTAL STRUCTURE OF HUMAN PROTEIN KINASE CK2 HOLOENZYME  |   CASEIN KINASE 2, CK2 HOLOENZYME, PROTEIN KINASE CK2, TRANSFERASE 
4n0s:A    (GLY37) to   (VAL173)  COMPLEX OF ERK2 WITH CAFFEIC ACID  |   CAFFEIC ACID COMPLEX, MITOGEN-ACTIVATED PROTEIN KINASE, SIGNAL- REGULATED KINASE, TRANSFERASE 
5b0x:A    (GLU55) to   (PHE181)  CRYSTAL STRUCTURE OF THE CK2A/BENZOIC ACID DERIVATIVE COMPLEX  |   INHIBITOR, COMPLEX, KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
2jbo:A    (LEU79) to   (THR215)  PROTEIN KINASE MK2 IN COMPLEX WITH AN INHIBITOR (CRYSTAL FORM-1, SOAKING)  |   SER-THR KINASE, MAPKAP KINASE 2, PHOSPHORYLATION, MK2, KINASE, ATP SITE, TRANSFERASE, ATP-BINDING, SERINE/THREONINE-PROTEIN KINASE, SMALL MOLECULE INHIBITOR, NUCLEOTIDE-BINDING 
2jbp:A    (LEU79) to   (THR214)  PROTEIN KINASE MK2 IN COMPLEX WITH AN INHIBITOR (CRYSTAL FORM-2, CO-CRYSTALLIZATION)  |   SER-THR KINASE, MAPKAP KINASE 2, PHOSPHORYLATION, SMALL MOLECULE INHIBITOR, MK2, KINASE, ATP SITE, TRANSFERASE, ATP- BINDING, SERINE/THREONINE-PROTEIN KINASE, CO- CRYSTALLIZATION, NUCLEOTIDE-BINDING 
2jbp:B    (LYS77) to   (THR214)  PROTEIN KINASE MK2 IN COMPLEX WITH AN INHIBITOR (CRYSTAL FORM-2, CO-CRYSTALLIZATION)  |   SER-THR KINASE, MAPKAP KINASE 2, PHOSPHORYLATION, SMALL MOLECULE INHIBITOR, MK2, KINASE, ATP SITE, TRANSFERASE, ATP- BINDING, SERINE/THREONINE-PROTEIN KINASE, CO- CRYSTALLIZATION, NUCLEOTIDE-BINDING 
2jbp:E    (LEU79) to   (THR215)  PROTEIN KINASE MK2 IN COMPLEX WITH AN INHIBITOR (CRYSTAL FORM-2, CO-CRYSTALLIZATION)  |   SER-THR KINASE, MAPKAP KINASE 2, PHOSPHORYLATION, SMALL MOLECULE INHIBITOR, MK2, KINASE, ATP SITE, TRANSFERASE, ATP- BINDING, SERINE/THREONINE-PROTEIN KINASE, CO- CRYSTALLIZATION, NUCLEOTIDE-BINDING 
2jbp:F    (GLY76) to   (THR215)  PROTEIN KINASE MK2 IN COMPLEX WITH AN INHIBITOR (CRYSTAL FORM-2, CO-CRYSTALLIZATION)  |   SER-THR KINASE, MAPKAP KINASE 2, PHOSPHORYLATION, SMALL MOLECULE INHIBITOR, MK2, KINASE, ATP SITE, TRANSFERASE, ATP- BINDING, SERINE/THREONINE-PROTEIN KINASE, CO- CRYSTALLIZATION, NUCLEOTIDE-BINDING 
2jbp:G    (GLY76) to   (THR215)  PROTEIN KINASE MK2 IN COMPLEX WITH AN INHIBITOR (CRYSTAL FORM-2, CO-CRYSTALLIZATION)  |   SER-THR KINASE, MAPKAP KINASE 2, PHOSPHORYLATION, SMALL MOLECULE INHIBITOR, MK2, KINASE, ATP SITE, TRANSFERASE, ATP- BINDING, SERINE/THREONINE-PROTEIN KINASE, CO- CRYSTALLIZATION, NUCLEOTIDE-BINDING 
2jbp:K    (LYS77) to   (THR214)  PROTEIN KINASE MK2 IN COMPLEX WITH AN INHIBITOR (CRYSTAL FORM-2, CO-CRYSTALLIZATION)  |   SER-THR KINASE, MAPKAP KINASE 2, PHOSPHORYLATION, SMALL MOLECULE INHIBITOR, MK2, KINASE, ATP SITE, TRANSFERASE, ATP- BINDING, SERINE/THREONINE-PROTEIN KINASE, CO- CRYSTALLIZATION, NUCLEOTIDE-BINDING 
2jbp:L    (LYS77) to   (THR215)  PROTEIN KINASE MK2 IN COMPLEX WITH AN INHIBITOR (CRYSTAL FORM-2, CO-CRYSTALLIZATION)  |   SER-THR KINASE, MAPKAP KINASE 2, PHOSPHORYLATION, SMALL MOLECULE INHIBITOR, MK2, KINASE, ATP SITE, TRANSFERASE, ATP- BINDING, SERINE/THREONINE-PROTEIN KINASE, CO- CRYSTALLIZATION, NUCLEOTIDE-BINDING 
3zc6:B   (GLY834) to   (LEU974)  CRYSTAL STRUCTURE OF JAK3 KINASE DOMAIN IN COMPLEX WITH AN INDAZOLE SUBSTITUTED PYRROLOPYRAZINE INHIBITOR  |   TRANSFERASE, SCID, SEVERE COMBINED IMMUNODEFICIENCY, STAT5, STAT6, INTERLEUKIN-2, COMMON-GAMMA CHAIN, ATP SITE KINASE INHIBITOR, CANCER 
2jfm:A    (GLY46) to   (THR181)  CRYSTAL STRUCTURE OF HUMAN STE20-LIKE KINASE (UNLIGANDED FORM)  |   TRANSFERASE, SERINE/THREONINE-PROTEIN KINASE, ATP-BINDING, PHOSPHORYLATION, MUSCLE DEVELOPMENT, KINASE, APOPTOSIS, GERMINAL CENTRE KINASE, SERINE- THREONINE KINASE 2, NUCLEOTIDE-BINDING, SERINE-THREONINE-PROTEIN KINASE 
5bms:A   (ILE334) to   (SER466)  CRYSTAL STRUCTURE OF P21-ACTIVATED KINASE 4 IN COMPLEX WITH AN INHIBITOR COMPOUND 29  |   KINASE, INHIBITOR, COMPLEX, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
2jii:B   (GLY178) to   (CYS334)  STRUCTURE OF VACCINIA RELATED KINASE 3  |   TRANSFERASE, PSEUDO KINASE DOMAIN, VACCINIA RELATED KINASE, SERINE/THREONINE-PROTEIN KINASE, VRK3, KINASE, ATP-BINDING, NUCLEOTIDE-BINDING 
4nct:B   (GLN172) to   (LEU314)  HUMAN DYRK1A IN COMPLEX WITH PKC412  |   PROTEIN KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
5bui:A    (GLY35) to   (VAL171)  ERK2 COMPLEXED WITH 2-PYRIDIYL TETRAHYDROAZAINDAZOLE  |   ERK2, MITOGEN-ACTIVATED PROTEIN KINASE 1, ATP-INHIBITOR, TRANSFERASE- TRANSFERASE INHIBITOR COMPLEX 
5buj:A    (GLY35) to   (ALA172)  ERK2 COMPLEXED WITH A N-H TETRAHYDROAZAINDAZOLE  |   ERK2, MITOGEN-ACTIVATED PROTEIN KINASE 1, ATP INHIBITOR, TRANSFERASE- TRANSFERASE INHIBITOR COMPLEX 
5bve:A    (GLY35) to   (VAL171)  TETRAHYDROPYRROLO-DIAZEPENONES AS INHIBITORS OF ERK2 KINASE  |   INHIBITOR, KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4nh1:A    (SER51) to   (PHE181)  CRYSTAL STRUCTURE OF A HETEROTETRAMERIC CK2 HOLOENZYME COMPLEX CARRYING THE ANDANTE-MUTATION IN CK2BETA AND CONSISTENT WITH PROPOSED MODELS OF AUTOINHIBITION AND TRANS-AUTOPHOSPHORYLATION  |   EUKARYOTIC PROTEIN KINASE FOLD, PHOSPHOTRANSFERASE (KINASE), PHOSPHORYLATION, TRANSFERASE 
4nh1:B    (SER51) to   (PHE181)  CRYSTAL STRUCTURE OF A HETEROTETRAMERIC CK2 HOLOENZYME COMPLEX CARRYING THE ANDANTE-MUTATION IN CK2BETA AND CONSISTENT WITH PROPOSED MODELS OF AUTOINHIBITION AND TRANS-AUTOPHOSPHORYLATION  |   EUKARYOTIC PROTEIN KINASE FOLD, PHOSPHOTRANSFERASE (KINASE), PHOSPHORYLATION, TRANSFERASE 
4nif:B    (GLY37) to   (ALA174)  HETERODIMERIC STRUCTURE OF ERK2 AND RSK1  |   KINASE DOMAIN, SIGNALING, SUBSTRATE KINASE BINDING, TRANSFERASE 
4nif:E    (GLY37) to   (VAL173)  HETERODIMERIC STRUCTURE OF ERK2 AND RSK1  |   KINASE DOMAIN, SIGNALING, SUBSTRATE KINASE BINDING, TRANSFERASE 
4njd:A   (GLY333) to   (SER466)  STRUCTURE OF P21-ACTIVATED KINASE 4 WITH A NOVEL INHIBITOR KY-04031  |   KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
2y9q:A    (GLY37) to   (ALA174)  CRYSTAL STRUCTURE OF HUMAN ERK2 COMPLEXED WITH A MAPK DOCKING PEPTIDE  |   TRANSFERASE, SIGNALING, PROTEIN-PROTEIN INTERACTION 
3zu7:A    (MET36) to   (VAL171)  CRYSTAL STRUCTURE OF A DESIGNED SELECTED ANKYRIN REPEAT PROTEIN IN COMPLEX WITH THE MAP KINASE ERK2  |   TRANSFERASE-DE NOVO PROTEIN COMPLEX, TRANSFERASE, SELECTED BINDER, PROTEIN DESIGN 
3zuv:A    (GLY35) to   (ASP175)  CRYSTAL STRUCTURE OF A DESIGNED SELECTED ANKYRIN REPEAT PROTEIN IN COMPLEX WITH THE PHOSPHORYLATED MAP KINASE ERK2  |   DE NOVO PROTEIN-TRANSFERASE COMPLEX, ANKYRIN REPEAT PROTEIN, SELECTED BINDER, PROTEIN DESIGN 
4nu1:A    (GLY68) to   (GLN206)  CRYSTAL STRUCTURE OF A TRANSITION STATE MIMIC OF THE GSK-3/AXIN COMPLEX BOUND TO PHOSPHORYLATED N-TERMINAL AUTO-INHIBITORY PS9 PEPTIDE  |   WNT, LRP6, GSK-3, AXIN, KINASE, PRIMED SUBSTRATE, TRANSITION STATE, PHOSPHORYLATED N-TERMINAL AUTO-INHIBITORY PS9 PEPTIDE, TRANSFERASE- PEPTIDE COMPLEX 
4o0y:A   (ILE334) to   (SER466)  BACK POCKET FLEXIBILITY PROVIDES GROUP-II PAK SELECTIVITY FOR TYPE 1 KINASE INHIBITORS  |   PAK4, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
2nru:B   (VAL199) to   (GLU337)  CRYSTAL STRUCTURE OF IRAK-4  |   KINASE, INHIBITOR, IRAK, TRANSFERASE 
2nru:D   (VAL199) to   (GLU337)  CRYSTAL STRUCTURE OF IRAK-4  |   KINASE, INHIBITOR, IRAK, TRANSFERASE 
2nry:B   (GLY198) to   (SER336)  CRYSTAL STRUCTURE OF IRAK-4  |   KINASE, INHIBITOR, STAUROSPORINE, TRANSFERASE 
2nry:C   (GLY198) to   (SER336)  CRYSTAL STRUCTURE OF IRAK-4  |   KINASE, INHIBITOR, STAUROSPORINE, TRANSFERASE 
3juh:B    (SER51) to   (PHE181)  CRYSTAL STRUCTURE OF A MUTANT OF HUMAN PROTEIN KINASE CK2ALPHA WITH ALTERED COSUBSTRATE SPECIFICITY  |   EUKARYOTIC PROTEIN KINASE, ATP-BINDING, KINASE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE, WNT SIGNALING PATHWAY 
4o6e:A    (GLY37) to   (VAL173)  DISCOVERY OF 5,6,7,8-TETRAHYDROPYRIDO[3,4-D]PYRIMIDINE INHIBITORS OF ERK2  |   PROTEIN KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
5cf4:A   (GLY861) to  (GLN1003)  CRYSTAL STRUCTURE OF JANUS KINASE 2 IN COMPLEX WITH N,N-DICYCLOPROPYL- 10-ETHYL-7-[(3-METHOXYPROPYL)AMINO] -3-METHYL-3,5,8,10- TETRAAZATRICYCLO[7.3.0.0,6] DODECA-1(9),2(6),4,7,11-PENTAENE-11- CARBOXAMIDE  |   KINASE, TRANSFERASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
5cf4:B   (GLY861) to  (GLN1003)  CRYSTAL STRUCTURE OF JANUS KINASE 2 IN COMPLEX WITH N,N-DICYCLOPROPYL- 10-ETHYL-7-[(3-METHOXYPROPYL)AMINO] -3-METHYL-3,5,8,10- TETRAAZATRICYCLO[7.3.0.0,6] DODECA-1(9),2(6),4,7,11-PENTAENE-11- CARBOXAMIDE  |   KINASE, TRANSFERASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
5cf5:A   (GLY861) to  (GLN1003)  CRYSTAL STRUCTURE OF JANUS KINASE 2 IN COMPLEX WITH N,N-DICYCLOPROPYL- 7-[(DIMETHYL-1,3-THIAZOL-2-YL)AMINO]-10-ETHYL-3-METHYL-3,5,8,10- TETRAAZATRICYCLO[7.3.0.02,6] DODECA-1(9),2(6),4,7,11-PENTAENE-11- CARBOXAMIDE  |   KINASE, TRANSFERASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
5cf5:B   (GLY861) to  (GLN1003)  CRYSTAL STRUCTURE OF JANUS KINASE 2 IN COMPLEX WITH N,N-DICYCLOPROPYL- 7-[(DIMETHYL-1,3-THIAZOL-2-YL)AMINO]-10-ETHYL-3-METHYL-3,5,8,10- TETRAAZATRICYCLO[7.3.0.02,6] DODECA-1(9),2(6),4,7,11-PENTAENE-11- CARBOXAMIDE  |   KINASE, TRANSFERASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
5cf6:A   (GLY861) to  (GLN1003)  CRYSTAL STRUCTURE OF JANUS KINASE 2 IN COMPLEX WITH N,N-DICYCLOPROPYL- 10-[(2S)-2,3-DIHYDROXYPROPYL]-3-METHYL-7-(METHYLAMINO)-3,5,8,10- TETRAAZATRICYCLO [7.3.0.02,6]DODECA-1(9),2(6),4,7,11-PENTAENE-11- CARBOXAMIDE  |   KINASE, TRANSFERASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
5cf6:B   (GLY861) to  (GLN1003)  CRYSTAL STRUCTURE OF JANUS KINASE 2 IN COMPLEX WITH N,N-DICYCLOPROPYL- 10-[(2S)-2,3-DIHYDROXYPROPYL]-3-METHYL-7-(METHYLAMINO)-3,5,8,10- TETRAAZATRICYCLO [7.3.0.02,6]DODECA-1(9),2(6),4,7,11-PENTAENE-11- CARBOXAMIDE  |   KINASE, TRANSFERASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3jy9:A   (GLY861) to  (GLN1003)  JANUS KINASE 2 INHIBITORS  |   KINASE, INHIBITOR, JAK2, JANUS KINASE, ATP-BINDING, DISEASE MUTATION, MEMBRANE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, PROTO-ONCOGENE, SH2 DOMAIN, TRANSFERASE, TYROSINE-PROTEIN KINASE 
3k2l:A   (GLY161) to   (TYR301)  CRYSTAL STRUCTURE OF DUAL-SPECIFICITY TYROSINE PHOSPHORYLATION REGULATED KINASE 2 (DYRK2)  |   DYRK2, DUAL-SPECIFICITY TYROSINE-(Y)-PHOSPHORYLATION REGULATED KINASE 2, PSK-H2, KINASE, STRUCTURAL GENOMICS CONSORTIUM, SGC, APOPTOSIS, ATP-BINDING, MAGNESIUM, MANGANESE, NUCLEOTIDE-BINDING, NUCLEUS, PHOSPHOPROTEIN, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE, TYROSINE-PROTEIN KINASE 
4ogr:E    (GLU32) to   (ALA173)  CRYSTAL STRUCTURE OF P-TEFB COMPLEX WITH AFF4 AND TAT  |   P-TEFB, CYCLIN-DEPENDENT KINASE 9, CYCLIN FOLD, INTRINSICALLY UNSTRUCTURED AFF4, TRANSCRIPTIONAL REGULATION AT HIV PROMOTER, BINDS TAR, N-TERMINAL ACETYLATION OF TAT, TRANSFERASE-VIRAL PROTEIN COMPLEX 
5clp:B    (SER51) to   (PHE181)  CRYSTAL STRUCTURE OF CK2ALPHA WITH 3,4-DICHLOROPHENETHYLAMINE BOUND  |   TRANSFERASE, CK2ALPHA, CK2A, FRAGMENT BASED DRUG DISCOVERY, HIGH CONCENTRATION SCREENING, SELECTIVE ATP COMPETITIVE INHIBITORS, SURFACE ENTROPHY REDUCTION 
4oh4:A   (GLY895) to  (SER1035)  CRYSTAL STRUCTURE OF BRI1 IN COMPLEX WITH BKI1  |   KINASE DOMAIN, TRANSFERASE, ATP BINDING, PHOSPHORYLATION, MEMBRANE, TRANSFERASE-SIGNALING PROTEIN COMPLEX 
1lpu:A    (SER51) to   (PHE181)  LOW TEMPERATURE CRYSTAL STRUCTURE OF THE APO-FORM OF THE CATALYTIC SUBUNIT OF PROTEIN KINASE CK2 FROM ZEA MAYS  |   PROTEIN KINASE, CK2, CASEIN KINASE 2, DUAL-COSUBSTRATE SPECIFICITY, TRANSFERASE 
5cqw:A    (SER51) to   (PHE181)  TETRAGONAL COMPLEX STRUCTURE OF PROTEIN KINASE CK2 CATALYTIC SUBUNIT WITH A BENZOTRIAZOLE-BASED INHIBITOR GENERATED BY CLICK-CHEMISTRY  |   TRANSFERASE, ATP-COMPETITIVE INHIBITOR, PROTEIN KINASE CK2, CASEIN KINASE 2 
5cqw:B    (SER51) to   (PHE181)  TETRAGONAL COMPLEX STRUCTURE OF PROTEIN KINASE CK2 CATALYTIC SUBUNIT WITH A BENZOTRIAZOLE-BASED INHIBITOR GENERATED BY CLICK-CHEMISTRY  |   TRANSFERASE, ATP-COMPETITIVE INHIBITOR, PROTEIN KINASE CK2, CASEIN KINASE 2 
1xo2:B    (LYS26) to   (TYR170)  CRYSTAL STRUCTURE OF A HUMAN CYCLIN-DEPENDENT KINASE 6 COMPLEX WITH A FLAVONOL INHIBITOR, FISETIN  |   CRYSTAL STRUCTURE,HUMAN CYCLIN-DEPENDENT KINASE 6, FISETIN, CELL CYCLE-TRANSFERASE COMPLEX 
1m2p:A    (GLU55) to   (PHE181)  CRYSTAL STRUCTURE OF 1,8-DI-HYDROXY-4-NITRO- ANTHRAQUINONE/CK2 KINASE COMPLEX  |   KINASE, INHIBITOR-ENZYME COMPLEX, TRANSFERASE 
1m2q:A    (TYR50) to   (PHE181)  CRYSTAL STRUCTURE OF 1,8-DI-HYDROXY-4-NITRO-XANTEN-9- ONE/CK2 KINASE COMPLEX  |   KINASE, INHIBITOR-ENZYME COMPLEX, TRANSFERASE 
5ct0:A    (SER51) to   (PHE181)  CRYSTAL STRUCTURE OF CK2ALPHA WITH 3-(3-CHLORO-4-(PHENYL)BENZYLAMINO) PROPAN-1-OL BOUND  |   CK2ALPHA, CK2A, FRAGMENT BASED DRUG DISCOVERY, HIGH CONCENTRATION SCREENING, SELECTIVE ATP COMPETITIVE INHIBITORS, SURFACE ENTROPHY REDUCTION, TRANSFERASE 
3kcf:B   (GLY217) to   (ASP359)  CRYSTAL STRUCTURE OF TGFBRI COMPLEXED WITH A PYRAZOLONE INHIBITOR  |   KINASE, TGFBETARI, STRUCTURE-BASED DRUG DESIGN, PROTEIN- INHIBITOR COMPLEX, AORTIC ANEURYSM, ATP-BINDING, CRANIOSYNOSTOSIS, DISEASE MUTATION, DISULFIDE BOND, GLYCOPROTEIN, MAGNESIUM, MANGANESE, MEMBRANE, METAL- BINDING, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, POLYMORPHISM, RECEPTOR, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE, TRANSMEMBRANE 
3kck:A   (GLY861) to  (LEU1001)  A NOVEL CHEMOTYPE OF KINASE INHIBITORS  |   KINASE, INHIBITOR, JAK2, JANUS KINASE, ATP-BINDING, CHROMOSOMAL REARRANGEMENT, DISEASE MUTATION, MEMBRANE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, POLYMORPHISM, PROTO- ONCOGENE, SH2 DOMAIN, TRANSFERASE, TYROSINE-PROTEIN KINASE 
5cu2:B    (SER51) to   (PHE181)  CRYSTAL STRUCTURE OF CK2ALPHA WITH 2-HYDROXY-5-METHYLBENZOIC ACID AND (METHYL 4-((3-(3-CHLORO-4-(PHENYL)BENZYLAMINO)PROPYL)AMINO)-4- OXOBUTANOAT BOUND  |   CK2ALPHA, CK2A, FRAGMENT BASED DRUG DISCOVERY, HIGH CONCENTRATION SCREENING, SELECTIVE ATP COMPETITIVE INHIBITORS, SURFACE ENTROPHY REDUCTION, TRANSFERASE 
5cu3:A    (GLU55) to   (PHE181)  CRYSTAL STRUCTURE OF CK2ALPHA WITH COMPOUND 10 BOUND  |   CK2ALPHA, CK2A, FRAGMENT BASED DRUG DISCOVERY, HIGH CONCENTRATION SCREENING, SELECTIVE ATP COMPETITIVE INHIBITORS, SURFACE ENTROPHY REDUCTION, TRANSFERASE 
5cu3:B    (GLU55) to   (PHE181)  CRYSTAL STRUCTURE OF CK2ALPHA WITH COMPOUND 10 BOUND  |   CK2ALPHA, CK2A, FRAGMENT BASED DRUG DISCOVERY, HIGH CONCENTRATION SCREENING, SELECTIVE ATP COMPETITIVE INHIBITORS, SURFACE ENTROPHY REDUCTION, TRANSFERASE 
2zjw:A    (GLU55) to   (PHE181)  CRYSTAL STRUCTURE OF HUMAN CK2 ALPHA COMPLEXED WITH ELLAGIC ACID  |   PROTEIN-INHIBITOR COMPLEX, ATP-BINDING, KINASE, NUCLEOTIDE- BINDING, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE, WNT SIGNALING PATHWAY 
5cvf:A    (SER51) to   (PHE181)  CRYSTAL STRUCTURE OF CK2ALPHA WITH COMPOUND 5 BOUND  |   CK2ALPHA, CK2A, FRAGMENT BASED DRUG DISCOVERY, HIGH CONCENTRATION SCREENING, SELECTIVE ATP COMPETITIVE INHIBITORS, SURFACE ENTROPHY REDUCTION, TRANSFERASE 
5cvh:A    (SER51) to   (PHE181)  CRYSTAL STRUCTURE OF CK2ALPHA  |   CK2ALPHA, CK2A, FRAGMENT BASED DRUG DISCOVERY, HIGH CONCENTRATION SCREENING, SELECTIVE ATP COMPETITIVE INHIBITORS, SURFACE ENTROPHY REDUCTION, TRANSFERASE 
5cvh:B    (SER51) to   (PHE181)  CRYSTAL STRUCTURE OF CK2ALPHA  |   CK2ALPHA, CK2A, FRAGMENT BASED DRUG DISCOVERY, HIGH CONCENTRATION SCREENING, SELECTIVE ATP COMPETITIVE INHIBITORS, SURFACE ENTROPHY REDUCTION, TRANSFERASE 
4or5:A    (GLU32) to   (ALA173)  CRYSTAL STRUCTURE OF HIV-1 TAT COMPLEXED WITH HUMAN P-TEFB AND AFF4  |   CDK9, TAT, AFF4, ZINC FINGER, TRANSCRIPTION, RNA BINDING, PHOSPHORYLATION, TRANSFERASE-TRANSCRIPTION COMPLEX 
5cx9:B    (SER51) to   (PHE181)  CRYSTAL STRUCTURE OF CK2ALPHA WITH (METHYL 4-((3-(3-CHLORO-4-(PHENYL) BENZYLAMINO)PROPYL)AMINO)-4-OXOBUTANOATE BOUND  |   CK2ALPHA, CK2A, FRAGMENT BASED DRUG DISCOVERY, HIGH CONCENTRATION SCREENING, SELECTIVE ATP COMPETITIVE INHIBITORS, SURFACE ENTROPHY REDUCTION, TRANSFERASE 
2zoq:A    (GLY54) to   (ALA191)  STRUCTURAL DISSECTION OF HUMAN MITOGEN-ACTIVATED KINASE ERK1  |   SERINE/THREONINE KINASE, ERK1, ACETYLATION, ATP-BINDING, CELL CYCLE, HOST-VIRUS INTERACTION, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, POLYMORPHISM, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE 
3kga:A    (ASN75) to   (THR214)  CRYSTAL STRUCTURE OF MAPKAP KINASE 2 (MK2) COMPLEXED WITH A POTENT 3-AMINOPYRAZOLE ATP SITE INHIBITOR  |   SMALL MOLECULE INHIBITOR, 3-AMINOPYRAZOLE SCAFFOLD, SCAFFOLD HOPING, ATP-SITE KINASE INHIBITOR, INDUCED FIT, NOVEL HYDROPHOBIC POCKET, ACTIVATION LOOP DELETION, ALTERNATIVE SPLICING, ATP-BINDING, KINASE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, POLYMORPHISM, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE 
3kl8:C    (SER25) to   (VAL163)  CAMKIINTIDE INHIBITOR COMPLEX  |   CAMKII, CAMKIINTIDE, ATP-BINDING, KINASE, NUCLEOTIDE-BINDING, SERINE/THREONINE-PROTEIN KINASE, CELL JUNCTION, CELL MEMBRANE, MEMBRANE, POSTSYNAPTIC CELL MEMBRANE, PROTEIN KINASE INHIBITOR, SYNAPSE, SYNAPTOSOME, TRANSFERASE- TRANSFERASE INHIBITOR COMPLEX 
3kl8:E    (SER25) to   (VAL163)  CAMKIINTIDE INHIBITOR COMPLEX  |   CAMKII, CAMKIINTIDE, ATP-BINDING, KINASE, NUCLEOTIDE-BINDING, SERINE/THREONINE-PROTEIN KINASE, CELL JUNCTION, CELL MEMBRANE, MEMBRANE, POSTSYNAPTIC CELL MEMBRANE, PROTEIN KINASE INHIBITOR, SYNAPSE, SYNAPTOSOME, TRANSFERASE- TRANSFERASE INHIBITOR COMPLEX 
3kl8:G    (SER25) to   (VAL163)  CAMKIINTIDE INHIBITOR COMPLEX  |   CAMKII, CAMKIINTIDE, ATP-BINDING, KINASE, NUCLEOTIDE-BINDING, SERINE/THREONINE-PROTEIN KINASE, CELL JUNCTION, CELL MEMBRANE, MEMBRANE, POSTSYNAPTIC CELL MEMBRANE, PROTEIN KINASE INHIBITOR, SYNAPSE, SYNAPTOSOME, TRANSFERASE- TRANSFERASE INHIBITOR COMPLEX 
3kl8:I    (SER25) to   (VAL163)  CAMKIINTIDE INHIBITOR COMPLEX  |   CAMKII, CAMKIINTIDE, ATP-BINDING, KINASE, NUCLEOTIDE-BINDING, SERINE/THREONINE-PROTEIN KINASE, CELL JUNCTION, CELL MEMBRANE, MEMBRANE, POSTSYNAPTIC CELL MEMBRANE, PROTEIN KINASE INHIBITOR, SYNAPSE, SYNAPTOSOME, TRANSFERASE- TRANSFERASE INHIBITOR COMPLEX 
4p7e:A   (GLY861) to  (GLN1003)  TRIAZOLOPYRIDINE COMPOUNDS AS SELECTIVE JAK1 INHIBITORS: FROM HIT IDENTIFICATION TO GLPG0634  |   TRANSFERASE, JAK1 INHIBITOR, TRIAZOLOPYRIDINE 
4p7e:B   (GLY861) to  (GLN1003)  TRIAZOLOPYRIDINE COMPOUNDS AS SELECTIVE JAK1 INHIBITORS: FROM HIT IDENTIFICATION TO GLPG0634  |   TRANSFERASE, JAK1 INHIBITOR, TRIAZOLOPYRIDINE 
4p90:A   (GLY282) to   (ILE414)  CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF HUMAN PAK1 IN COMPLEX WITH COMPOUND 15  |   INHIBITOR, KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4pdp:A   (ALA210) to   (GLN346)  CRYSTAL STRUCTURE OF RAD53 KINASE DOMAIN AND SCD2  |   SER/THR KINASE DOMAIN, N-LOBE, C-LOBE, ACTIVATION SEGMENT EXCHANGE, TRANSFERASE 
4pdp:B   (LYS213) to   (GLN346)  CRYSTAL STRUCTURE OF RAD53 KINASE DOMAIN AND SCD2  |   SER/THR KINASE DOMAIN, N-LOBE, C-LOBE, ACTIVATION SEGMENT EXCHANGE, TRANSFERASE 
3a7g:B    (LYS40) to   (THR170)  HUMAN MST3 KINASE  |   TWO-LOBE PROTEIN KINASE FOLD, ATP-BINDING, KINASE, NUCLEOTIDE- BINDING, TRANSFERASE 
3kxg:A    (GLU55) to   (PHE181)  CRYSTAL STRUCTURE OF Z. MAYS CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE INHIBITOR 3,4,5,6,7-PENTABROMO-1H-INDAZOLE (K64)  |   PROTEIN KINASE CK2-INHIBITOR COMPLEX, ATP-BINDING, KINASE, NUCLEOTIDE-BINDING, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3kxh:A    (SER51) to   (TYR182)  CRYSTAL STRUCTURE OF Z. MAYS CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE INHIBITOR (2-DYMETHYLAMMINO-4,5,6,7-TETRABROMOBENZOIMIDAZOL-1YL- ACETIC ACID (K66)  |   PROTEIN KINASE CK2-INHIBITOR COMPLEX, ATP-BINDING, KINASE, NUCLEOTIDE-BINDING, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3kxm:A    (GLU55) to   (PHE181)  CRYSTAL STRUCTURE OF Z. MAYS CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE INHIBITOR K74  |   PROTEIN KINASE CK2-INHIBITOR COMPLEX, ATP-BINDING, KINASE, NUCLEOTIDE-BINDING, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3kxn:A    (GLU55) to   (PHE181)  CRYSTAL STRUCTURE OF Z. MAYS CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE INHIBITOR TETRAIODOBENZIMIDAZOLE (K88)  |   PROTEIN KINASE CK2-INHIBITOR COMPLEX, ATP-BINDING, KINASE, NUCLEOTIDE-BINDING, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
5dew:A   (GLY282) to   (THR415)  CRYSTAL STRUCTURE OF PAK1 IN COMPLEX WITH AN INHIBITOR COMPOUND 5  |   TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
1yvj:A   (GLY834) to   (LEU974)  CRYSTAL STRUCTURE OF THE JAK3 KINASE DOMAIN IN COMPLEX WITH A STAUROSPORINE ANALOGUE  |   TYROSINE KINASE; SCID; SEVERE COMBINED IMMUNODEFICIENCY; STAT5; STAT6; INTERLEUKIN-2; COMMON-GAMMA CHAIN, TRANSFERASE 
4anm:A    (SER51) to   (PHE181)  COMPLEX OF CK2 WITH A CDC7 INHIBITOR  |   TRANSFERASE 
3amy:A    (SER51) to   (PHE181)  CRYSTAL STRUCTURE OF HUMAN CK2 ALPHA COMPLEXED WITH APIGENIN  |   TRANSFERASE, ATP-BINDING 
4py1:A   (GLY909) to  (GLU1050)  CRYSTAL STRUCTURE OF TYK2 IN COMPLEX WITH COMPOUND 15, 6-((2,5- DIMETHOXYPHENYL)THIO)-3-(1-METHYL-1H-PYRAZOL-4-YL)-[1,2,4]TRIAZOLO[4, 3-B]PYRIDAZINE  |   KINASE, TRANSFERASE 
3lpb:A   (PHE860) to  (GLN1003)  CRYSTAL STRUCTURE OF JAK2 COMPLEXED WITH A POTENT 2,8-DIARYL- QUINOXALINE INHIBITOR  |   SMALL MOLECULE INHIBITOR, ATP SITE KINASE INHIBITOR, NOVARTIS PRODUCT NVP-BLU040, ATP-BINDING, CHROMOSOMAL REARRANGEMENT, DISEASE MUTATION, KINASE, MEMBRANE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, POLYMORPHISM, PROTO-ONCOGENE, SH2 DOMAIN, TRANSFERASE, TYROSINE- PROTEIN KINASE 
3lpb:B   (GLY861) to  (GLN1003)  CRYSTAL STRUCTURE OF JAK2 COMPLEXED WITH A POTENT 2,8-DIARYL- QUINOXALINE INHIBITOR  |   SMALL MOLECULE INHIBITOR, ATP SITE KINASE INHIBITOR, NOVARTIS PRODUCT NVP-BLU040, ATP-BINDING, CHROMOSOMAL REARRANGEMENT, DISEASE MUTATION, KINASE, MEMBRANE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, POLYMORPHISM, PROTO-ONCOGENE, SH2 DOMAIN, TRANSFERASE, TYROSINE- PROTEIN KINASE 
1zog:A    (GLU52) to   (PHE181)  CRYSTAL STRUCTURE OF PROTEIN KINASE CK2 IN COMPLEX WITH TBB- DERIVATIVES  |   PROTEIN KINASE CK2, TBB, TETRABROMO-BENZIMIDAZOLE, INHIBITORS, PHARMACOPHORE, TRANSFERASE 
1zoh:A    (GLU55) to   (PHE181)  CRYSTAL STRUCTURE OF PROTEIN KINASE CK2 IN COMPLEX WITH TBB- DERIVATIVES INHIBITORS  |   PROTEIN KINASE CK2, TETRABROMO-BENZIMIDAZOLE, TBB, INHIBITORS, PHARMACOPHORE, TRANSFERASE 
4au8:A    (GLY16) to   (PHE151)  CRYSTAL STRUCTURE OF COMPOUND 4A IN COMPLEX WITH CDK5, SHOWING AN UNUSUAL BINDING MODE TO THE HINGE REGION VIA A WATER MOLECULE  |   TRANSFERASE, CDK2, ALZHEIMER DISEASE 
4au8:B    (GLY16) to   (PHE151)  CRYSTAL STRUCTURE OF COMPOUND 4A IN COMPLEX WITH CDK5, SHOWING AN UNUSUAL BINDING MODE TO THE HINGE REGION VIA A WATER MOLECULE  |   TRANSFERASE, CDK2, ALZHEIMER DISEASE 
5e1e:B   (PHE886) to  (THR1030)  HUMAN JAK1 KINASE IN COMPLEX WITH COMPOUND 30 AT 2.30 ANGSTROMS RESOLUTION  |   KINASE, TRANSFERASE 
3lxl:A   (GLY834) to   (LEU976)  STRUCTURAL AND THERMODYNAMIC CHARACTERIZATION OF THE TYK2 AND JAK3 KINASE DOMAINS IN COMPLEX WITH CP-690550 AND CMP-6  |   TYK2, JAK3, INFLAMMATION, CANCER, PAN INHIBITOR, ATP-BINDING, DISEASE MUTATION, KINASE, MEMBRANE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SCID, SH2 DOMAIN, TRANSFERASE, TYROSINE-PROTEIN KINASE 
3lxn:A   (GLY909) to  (GLU1050)  STRUCTURAL AND THERMODYNAMIC CHARACTERIZATION OF THE TYK2 AND JAK3 KINASE DOMAINS IN COMPLEX WITH CP-690550 AND CMP-6  |   TYK2, JAK3, INFLAMMATION, CANCER, PAN INHIBITOR, ATP-BINDING, KINASE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SH2 DOMAIN, TRANSFERASE, TYROSINE-PROTEIN KINASE 
3lxp:A   (LEU913) to  (GLU1050)  STRUCTURAL AND THERMODYNAMIC CHARACTERIZATION OF THE TYK2 AND JAK3 KINASE DOMAINS IN COMPLEX WITH CP-690550 AND CMP-6  |   TYK2, JAK3, INFLAMMATION, CANCER, PAN INHIBITOR, ATP-BINDING, KINASE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SH2 DOMAIN, TRANSFERASE, TYROSINE-PROTEIN KINASE 
2a1a:B   (GLY279) to   (LEU439)  PKR KINASE DOMAIN-EIF2ALPHA COMPLEX  |   TRANSFERASE, KINASE, PROTEIN BIOSYNTHESIS, PROTEIN SYNTHESIS- TRANSFERASE COMPLEX 
5e8v:A   (ALA256) to   (LEU404)  TGF-BETA RECEPTOR TYPE 2 KINASE DOMAIN (E431A,R433A,E485A,K488A,R493A, R495A)  |   KINASE DOMAIN, TRANSFERASE 
5e91:A   (ALA256) to   (LEU404)  TGF-BETA RECEPTOR TYPE 2 KINASE DOMAIN (E431A,R433A,E485A,K488A,R493A, R495A) IN COMPLEX WITH 3-AMINO-6-[4-(2- HYDROXYETHYL)PHENYL]-N-[4- (MORPHOLIN-4-YL)PYRIDIN-3-YL] PYRAZINE-2-CARBOXAMIDE  |   KINASE DOMAIN, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
5e92:A   (ALA256) to   (PRO406)  TGF-BETA RECEPTOR TYPE 2 KINASE DOMAIN (E431A,R433A,E485A,K488A,R493A, R495A) IN COMPLEX WITH AMPPNP  |   KINASE DOMAIN, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3m2w:A    (GLY76) to   (THR214)  CRYSTAL STRUCTURE OF MAPKAK KINASE 2 (MK2) COMPLEXED WITH A SPIROAZETIDINE-TETRACYCLIC ATP SITE INHIBITOR  |   SMALL MOLECULE INHIBITOR, SPIROAZETIDINE-TETRACYCLE, ATP-SITE KINASE INHIBITOR, NOVARTIS COMPOUND NVP-BXS169, ATP-BINDING, KINASE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE 
3axw:A    (SER51) to   (PHE181)  CRYSTAL STRUCTURE OF HUMAN CK2ALPHA COMPLEXED WITH A POTENT INHIBITOR  |   KINASE DOMAIN, SERINE/THREONINE KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
5ebz:C    (ASN28) to   (VAL172)  HUMAN KINASE  |   KINASE, INHIBITOR, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
5ebz:F    (ASN28) to   (VAL172)  HUMAN KINASE  |   KINASE, INHIBITOR, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
5ebz:G    (ASN28) to   (VAL172)  HUMAN KINASE  |   KINASE, INHIBITOR, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
5ebz:H    (ASN28) to   (VAL172)  HUMAN KINASE  |   KINASE, INHIBITOR, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
5ebz:I    (ASN28) to   (VAL172)  HUMAN KINASE  |   KINASE, INHIBITOR, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
5ebz:K    (ASN28) to   (VAL172)  HUMAN KINASE  |   KINASE, INHIBITOR, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
5ebz:L    (ASN28) to   (VAL172)  HUMAN KINASE  |   KINASE, INHIBITOR, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3mb6:A    (SER51) to   (PHE181)  HUMAN CK2 CATALYTIC DOMAIN IN COMPLEX WITH A DIFURANE DERIVATIVE INHIBITOR (CPA)  |   KINASES, DIFURANE, INHIBITOR, CK2, ATP-BINDING, KINASE, NUCLEOTIDE- BINDING, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE 
4qmw:A    (GLY36) to   (THR170)  MST3 IN COMPLEX WITH PP-121, 1-CYCLOPENTYL-3-(1H-PYRROLO[2,3- B]PYRIDIN-5-YL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE  |   PROTEIN KINASE, MST3, STK24, STERILE 20-LIKE KINASE, ATP-BINDING, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SERINE/THREONINE-TRANSFERASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4bcp:A    (VAL17) to   (ALA151)  STRUCTURE OF CDK2 IN COMPLEX WITH CYCLIN A AND A 2-AMINO-4- HETEROARYL-PYRIMIDINE INHIBITOR  |   TRANSFERASE-CELL CYCLE COMPLEX, CDK-CYCLIN COMPLEX, CYCLIN-INHIBITOR, STRUCTURE-BASED DRUG DESIGN 
4qp1:A    (GLY37) to   (VAL173)  CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH N-CYCLOHEXYL-9H-PURIN-6- AMINE  |   KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4qp1:B    (GLY37) to   (VAL173)  CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH N-CYCLOHEXYL-9H-PURIN-6- AMINE  |   KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4qp2:A    (GLY37) to   (VAL173)  CRYSTAL STRUCTURE OF ERKS IN COMPLEX WITH 5-CHLOROBENZO[D]OXAZOL-2- AMINE  |   KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4qp3:A    (MET38) to   (ALA174)  CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH (S)-2-((9H-PURIN-6-YL) AMINO)-3-PHENYLPROPAN-1-OL  |   KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4qp3:B    (GLY37) to   (VAL173)  CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH (S)-2-((9H-PURIN-6-YL) AMINO)-3-PHENYLPROPAN-1-OL  |   KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4qp4:A    (GLY37) to   (VAL173)  CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH N-CYCLOHEXYL-9H-PURIN-6- AMINE  |   KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4qp4:B    (GLY37) to   (VAL173)  CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH N-CYCLOHEXYL-9H-PURIN-6- AMINE  |   KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4qp6:A    (GLY37) to   (VAL173)  CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH 5H-PYRROLO[2,3-B]PYRAZINE  |   KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4qp6:B    (GLY37) to   (VAL173)  CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH 5H-PYRROLO[2,3-B]PYRAZINE  |   KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4qp8:A    (GLY37) to   (ALA174)  CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH 2-(1H-PYRAZOL-4-YL)-7- (PYRIDIN-3-YL)-5H-PYRROLO[2,3-B]PYRAZINE  |   KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4qp8:B    (GLY37) to   (ALA174)  CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH 2-(1H-PYRAZOL-4-YL)-7- (PYRIDIN-3-YL)-5H-PYRROLO[2,3-B]PYRAZINE  |   KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4qp9:A    (GLY37) to   (VAL173)  CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH 7-(1-PROPYL-1H-PYRAZOL-4- YL)-2-(PYRIDIN-4-YL)-5H-PYRROLO[2,3-B]PYRAZINE  |   KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4qpa:B    (GLY35) to   (VAL171)  CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH 7-(1-BENZYL-1H-PYRAZOL-4- YL)-2-(PYRIDIN-4-YL)-5H-PYRROLO[2,3-B]PYRAZINE  |   KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3mi9:A    (GLU32) to   (ALA173)  CRYSTAL STRUCTURE OF HIV-1 TAT COMPLEXED WITH HUMAN P-TEFB  |   P-TEFB, TAT, HIV-1, PROTEIN BINDING 
3mia:A    (GLU32) to   (ALA173)  CRYSTAL STRUCTURE OF HIV-1 TAT COMPLEXED WITH ATP-BOUND HUMAN P-TEFB  |   P-TEFB, CDK9, CYCLIN T1, HIV-1, TAT, PROTEIN BINDING 
4qps:C   (GLY834) to   (LEU976)  CRYSTAL STRUCTURE OF JAK3 COMPLEXED TO N-[3-(6-PHENYLAMINO-PYRAZIN-2- YL)-3H-BENZOIMIDAZOL-5-YL]-ACRYLAMIDE  |   KINASE CATALYTIC DOMAIN, TRANSFERASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4bid:B   (GLY692) to   (ARG828)  CRYSTAL STRUCTURES OF ASK1-INHIBITOR COMPLEXES  |   TRANSFERASE 
4qta:A    (GLY37) to   (ALA174)  STRUCTURE OF HUMAN ERK2 IN COMPLEX WITH SCH772984 REVEALING A NOVEL INHIBITOR-INDUCED BINDING POCKET  |   STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC, TRANSFERASE, KINASE, MAPK, SIGNALLING, INHIBITOR, ALLOSTERIC, STRUCTURAL GENOMICS CONSORTIUM (SGC), TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4qtb:A    (GLY54) to   (ALA191)  STRUCTURE OF HUMAN ERK1 IN COMPLEX WITH SCH772984 REVEALING A NOVEL INHIBITOR-INDUCED BINDING POCKET  |   STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC, TRANSFERASE, KINASE, MAPK, SIGNALLING, INHIBITOR, ALLOSTERIC, STRUCTURAL GENOMICS CONSORTIUM (SGC), TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4qtb:B    (GLY54) to   (ALA191)  STRUCTURE OF HUMAN ERK1 IN COMPLEX WITH SCH772984 REVEALING A NOVEL INHIBITOR-INDUCED BINDING POCKET  |   STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC, TRANSFERASE, KINASE, MAPK, SIGNALLING, INHIBITOR, ALLOSTERIC, STRUCTURAL GENOMICS CONSORTIUM (SGC), TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3blq:A    (GLY31) to   (ALA173)  CRYSTAL STRUCTURE OF HUMAN CDK9/CYCLINT1 IN COMPLEX WITH ATP  |   TRANSCRIPTIONAL CDK/CYCLIN COMPLEX, PHOSPHORYLATED, IN COMPLEX WITH ATP, ALTERNATIVE SPLICING, ATP-BINDING, KINASE, NUCLEOTIDE-BINDING, NUCLEUS, PHOSPHOPROTEIN, POLYMORPHISM, SERINE/THREONINE-PROTEIN KINASE, TRANSCRIPTION REGULATION, TRANSFERASE, ACETYLATION, CELL CYCLE, CELL DIVISION, COILED COIL, HOST-VIRUS INTERACTION 
5f1z:A   (LYS910) to  (GLU1050)  STRUCTURE OF TYK2 WITH INHIBITOR 16: 3-AZANYL-5-[(2~{S})-3- METHYLBUTAN-2-YL]-7-[1-METHYL-5-(2-OXIDANYLPROPAN-2-YL)PYRAZOL-3-YL]- 1~{H}-PYRAZOLO[4,3-C]PYRIDIN-4-ONE  |   KINASE, COMPLEX, INHIBITOR, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
5f20:A   (LYS910) to  (VAL1048)  STRUCTURE OF TYK2 WITH INHIBITOR 4: 3-AZANYL-5-(2-METHYLPHENYL)-7-(1- METHYLPYRAZOL-3-YL)-1~{H}-PYRAZOLO[4,3-C]PYRIDIN-4-ONE  |   KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3my0:U   (GLY214) to   (SER356)  CRYSTAL STRUCTURE OF THE ACVRL1 (ALK1) KINASE DOMAIN BOUND TO LDN- 193189  |   PROTEIN KINASE, SERINE/THREONINE-PROTEIN KINASE RECEPTOR, STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC, TRANSFERASE 
3nga:A    (GLU55) to   (PHE181)  HUMAN CK2 CATALYTIC DOMAIN IN COMPLEX WITH CX-4945  |   KINASE, CK2, INHIBITOR, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3nga:B    (SER51) to   (PHE181)  HUMAN CK2 CATALYTIC DOMAIN IN COMPLEX WITH CX-4945  |   KINASE, CK2, INHIBITOR, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3niz:A    (GLY35) to   (PHE169)  CRYPTOSPORIDIUM PARVUM CYCLIN-DEPENDENT KINASE CGD5_2510 WITH ADP BOUND.  |   STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC, PHOSPHOTRANSFERASE, CYCLIN DEPENDENT KINASE, TRANSFERASE 
4c61:A   (SER862) to  (GLN1003)  INHIBITORS OF JAK2 KINASE DOMAIN  |   KINASE, TRANSFERASE 
4c62:A   (GLY861) to  (GLN1003)  INHIBITORS OF JAK2 KINASE DOMAIN  |   TRANSFERASE 
4rlk:A    (SER51) to   (PHE181)  CRYSTAL STRUCTURE OF Z. MAYS CK2ALPHA IN COMPLEX WITH THE ATP- COMPETITIVE INHIBITOR 4-[(E)-(FLUOREN-9-YLIDENEHYDRAZINYLIDENE)- METHYL] BENZOATE  |   TRANSFERASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4rmz:A   (VAL199) to   (ALA335)  CRYSTAL STRUCTURE OF IRAK-4  |   SERINE/THREONINE PROTEIN KINASE, TRANSFERASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3nsz:A    (GLU55) to   (PHE181)  HUMAN CK2 CATALYTIC DOMAIN IN COMPLEX WITH AMPPN  |   KINASE, CK2, INHIBITOR, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3com:A    (SER43) to   (THR175)  CRYSTAL STRUCTURE OF MST1 KINASE  |   KINASE, MST1, SERINE/THREONINE-PROTEIN KINASE 4, STE20-LIKE KINASE, PSI, STRUCTURAL GENOMICS, PROTEIN STRUCTURE INITIATIVE, NEW YORK SGX RESEARCH CENTER FOR STRUCTURAL GENOMICS, NYSGXRC, ALTERNATIVE SPLICING, APOPTOSIS, ATP- BINDING, COILED COIL, CYTOPLASM, MAGNESIUM, METAL-BINDING, NUCLEOTIDE-BINDING, NUCLEUS, PHOSPHOPROTEIN, POLYMORPHISM, TRANSFERASE 
4ci6:B   (HIS144) to   (ARG292)  MECHANISMS OF CRIPPLING ACTIN-DEPENDENT PHAGOCYTOSIS BY YOPO  |   TRANSFERASE-STRUCTURAL PROTEIN COMPLEX, BUBONIC PLAGUE 
3nyx:A   (GLY909) to  (GLU1050)  NON-PHOSPHORYLATED TYK2 JH1 DOMAIN WITH QUINOLINE-THIADIAZOLE- THIOPHENE INHIBITOR  |   PROTEIN KINASE, TYROSINE PHOSPHORYLATION, TRANSFERASE, TRANSFERASE- TRANSFERASE INHIBITOR COMPLEX 
3nz0:A   (LEU913) to  (VAL1048)  NON-PHOSPHORYLATED TYK2 KINASE WITH CMP6  |   PROTEIN KINASE, TYROSINE PHOSPHORYLATION, TRANSFERASE 
3o0g:A    (GLY16) to   (GLY152)  CRYSTAL STRUCTURE OF CDK5:P25 IN COMPLEX WITH AN ATP ANALOGUE  |   KINASE, KINASE ACTIVATOR COMPLEX, KINASE INHIBITOR COMPLEX, TRANSFERASE-TRANSFERASE ACTIVATOR COMPLEX 
4s2z:A    (GLY35) to   (VAL171)  ERK2 INTRINSICALLY ACTIVE MUTANT R65S  |   SIGNAL TRANSDUCTION, PHOSPHORYLATION, KINASE, TRANSFERASE 
4s31:A    (GLY35) to   (VAL171)  CRYSTAL STRUCTURE OF MITOGEN-ACTIVATED PROTEIN KINASE 1 WTERK2 AT 1.45A  |   SIGNAL TRANSDUCTION, PHOSPHORYLATION, TRANSFERASE 
4s30:A    (GLY35) to   (VAL171)  ERK2 INTRINSICALLY ACTIVE MUTANT (I84A)  |   SIGNAL TRANSDUCTION, PHOSPHORYLATION, TRANSFERASE 
4s32:A    (GLY35) to   (VAL171)  CRYSTAL STRUCTURE OF ERK2 AMP-PNP COMPLEX  |   SIGNAL TRANSDUCTION, PHOSPHORYLATION, TRANSFERASE 
4s34:A    (GLY35) to   (VAL171)  ERK2 (I84A) IN COMPLEX WITH AMP-PNP  |   SIGNAL TRANSDUCTION, PHOSPHORYLATION, TRANSFERASE 
3d4q:B   (THR470) to   (VAL600)  PYRAZOLE-BASED INHIBITORS OF B-RAF KINASE  |   KINASE, ATP-BINDING, CARDIOMYOPATHY, DISEASE MUTATION, METAL-BINDING, NUCLEOTIDE-BINDING, PHORBOL-ESTER BINDING, PHOSPHOPROTEIN, PROTO- ONCOGENE, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE, ZINC-FINGER 
3d7z:A    (SER37) to   (THR175)  CRYSTAL STRUCTURE OF P38 KINASE IN COMPLEX WITH A BIPHENYL AMIDE INHIBITOR  |   P38, SERINE/THREONINE PROTEIN KINASE, MAP KINASE, ATP-BINDING, NUCLEOTIDE-BINDING, NUCLEUS, PHOSPHOPROTEIN, SERINE/THREONINE- PROTEIN KINASE, TRANSFERASE 
3dls:A  (TRP1014) to  (ARG1155)  CRYSTAL STRUCTURE OF HUMAN PAS KINASE BOUND TO ADP  |   PAS KINASE, PASK, PROTEIN KINASE, DRUG DISCOVERY, ATP-BINDING, KINASE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE, STRUCTURAL GENOMICS, PSI-2, PROTEIN STRUCTURE INITIATIVE, NEW YORK SGX RESEARCH CENTER FOR STRUCTURAL GENOMICS, NYSGXRC 
3dls:E  (TRP1014) to  (ARG1155)  CRYSTAL STRUCTURE OF HUMAN PAS KINASE BOUND TO ADP  |   PAS KINASE, PASK, PROTEIN KINASE, DRUG DISCOVERY, ATP-BINDING, KINASE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE, STRUCTURAL GENOMICS, PSI-2, PROTEIN STRUCTURE INITIATIVE, NEW YORK SGX RESEARCH CENTER FOR STRUCTURAL GENOMICS, NYSGXRC 
5h8b:A    (SER51) to   (PHE181)  CRYSTAL STRUCTURE OF CK2 WITH COMPOUND 2  |   KINASE, INHIBITOR, CK2, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
5h8b:B    (SER51) to   (PHE181)  CRYSTAL STRUCTURE OF CK2 WITH COMPOUND 2  |   KINASE, INHIBITOR, CK2, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
5h8e:A    (SER51) to   (PHE181)  CRYSTAL STRUCTURE OF CK2 WITH COMPOUND 7H  |   KINASE, INHIBITOR, CK2, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
5h8e:B    (SER51) to   (PHE181)  CRYSTAL STRUCTURE OF CK2 WITH COMPOUND 7H  |   KINASE, INHIBITOR, CK2, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
5h8g:A    (SER51) to   (PHE181)  CRYSTAL STRUCTURE OF CK2 WITH COMPOUND 7B  |   KINASE, INHIBITOR, CK2, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3owl:A    (SER51) to   (PHE181)  HUMAN CK2 CATALYTIC DOMAIN IN COMPLEX WITH A BENZOPYRIDOINDOLE DERIVATIVE INHIBITOR  |   SERINE/THREONINE-PROTEIN KINASE, CK2, INHIBITOR, PYRIDOCARBAZOL, ELLIPTICINE, TRANSFERASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4dgl:D    (SER51) to   (PHE181)  CRYSTAL STRUCTURE OF THE CK2 TETRAMERIC HOLOENZYME  |   PROTEIN KINASE, TRANSFERASE 
4dgm:A    (SER51) to   (PHE181)  CRYSTAL STRUCTURE OF MAIZE CK2 IN COMPLEX WITH THE INHIBITOR APIGENIN  |   PROTEIN KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4dgo:A    (SER51) to   (PHE181)  CRYSTAL STRUCTURE OF MAIZE CK2 IN COMPLEX WITH TYRPHOSTIN AG99  |   PROTEIN KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4dn5:A   (GLY412) to   (GLN542)  CRYSTAL STRUCTURE OF NF-KB-INDUCING KINASE (NIK)  |   NON-RD KINASE, PROTEIN SERINE/THREONINE KINASE, TRANSFERASE, ATP BINDING 
4ub7:A    (GLU52) to   (PHE181)  HIGH-SALT STRUCTURE OF PROTEIN KINASE CK2 CATALYTIC SUBUNIT WITH 4'- CARBOXY-6,8-BROMO-FLAVONOL (FLC26) SHOWING AN EXTREME DISTORTION OF THE ATP-BINDING LOOP COMBINED WITH A PI-HALOGEN BOND  |   PROTEIN KINASE CK2, ATP-COMPETITIVE INHIBITORS, HALOGEN BOND, 4'- CARBOXY-6, 8-BROMO-FLAVONOL, TRANSFERASE 
4uba:A    (SER51) to   (PHE181)  LOW-SALT STRUCTURE OF PROTEIN KINASE CK2 CATALYTIC SUBUNIT WITH 4'- CARBOXY-6,8-BROMO-FLAVONOL (FLC26)  |   PROTEIN KINASE CK2, ATP-COMPETITIVE INHIBITORS, HALOGEN BOND, 4'- CARBOXY-6, 8-BROMO-FLAVONOL, TRANSFERASE 
4uba:B    (SER51) to   (PHE181)  LOW-SALT STRUCTURE OF PROTEIN KINASE CK2 CATALYTIC SUBUNIT WITH 4'- CARBOXY-6,8-BROMO-FLAVONOL (FLC26)  |   PROTEIN KINASE CK2, ATP-COMPETITIVE INHIBITORS, HALOGEN BOND, 4'- CARBOXY-6, 8-BROMO-FLAVONOL, TRANSFERASE 
3e3p:B    (THR33) to   (LYS176)  GLYCOGEN SYNTHASE KINASE FROM LEISHMANIA MAJOR  |   GLYCOGEN SYNTHASE KINASE, LEISHMANIASIS, KINASE, TRANSFERASE 
5hvj:A   (GLY351) to   (MET485)  CRYSTAL STRUCTURE OF LIMK1 D460N MUTANT IN COMPLEX WITH AMP-PNP  |   KINASE ATP ANALOG ACTIN-REMODELING, TRANSFERASE 
5hvj:B   (PHE350) to   (LEU484)  CRYSTAL STRUCTURE OF LIMK1 D460N MUTANT IN COMPLEX WITH AMP-PNP  |   KINASE ATP ANALOG ACTIN-REMODELING, TRANSFERASE 
5hx8:A   (PHE886) to  (THR1030)  JAK1 COMPLEX WITH 4-[(4-AMINOCYCLOHEXYL)AMINO]-3-(1H-BENZIMIDAZOL-2- YL)-1H-PYRIDIN-2-ONE  |   KINASE, INHIBITOR, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3pe1:A    (SER51) to   (PHE181)  CRYSTAL STRUCTURE OF HUMAN PROTEIN KINASE CK2 ALPHA SUBUNIT IN COMPLEX WITH THE INHIBITOR CX-4945  |   KINASE, CK2-INHIBITOR COMPLEX, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3pe2:A    (SER51) to   (PHE181)  CRYSTAL STRUCTURE OF HUMAN PROTEIN KINASE CK2 IN COMPLEX WITH THE INHIBITOR CX-5011  |   KINASE, CK2-INHIBITOR COMPLEX, TRANSFERASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3pjc:A   (GLY834) to   (LEU976)  CRYSTAL STRUCTURE OF JAK3 COMPLEXED WITH A POTENT ATP SITE INHIBITOR SHOWING HIGH SELECTIVITY WITHIN THE JANUS KINASE FAMILY  |   SMALL MOLECULE INHIBITOR, ATP SITE KINASE INHIBITOR, ATP-BINDING, TRANSFERASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4e1z:A   (GLY905) to  (GLU1046)  STRUCTURE OF MOUSE TYK-2 COMPLEXED TO A 3-AMINOINDAZOLE INHIBITOR  |   KINASE CATALYTIC DOMAIN, KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4e20:A   (GLY905) to  (GLU1046)  STRUCTURE OF MOUSE TYK-2 COMPLEXED TO A 3-AMINOINDAZOLE INHIBITOR  |   KINASE CATALYTIC DOMAIN, KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3ppk:A   (LYS473) to   (VAL600)  HUMAN B-RAF KINASE IN COMPLEX WITH A NON-OXIME FUROPYRIDINE INHIBITOR  |   PROTEIN KINASE, B-RAF ATP-COMPETITIVE INHIBITOR, TRANSFERASE- TRANSFERASE INHIBITOR COMPLEX 
4e4l:B   (LEU891) to  (THR1030)  JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 30  |   O-PHOSPHOTYROSINE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4e4m:E   (GLY861) to  (LEU1001)  JAK2 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 30  |   O-PHOSPHOTYROSINE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4e4n:A   (GLY887) to  (THR1030)  JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 49  |   O-PHOSPHOTYROSINE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4e5w:A   (GLY887) to  (THR1030)  JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 26  |   JAK1, KINASE DOMAIN, KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4e5w:B   (LEU891) to  (ILE1028)  JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 26  |   JAK1, KINASE DOMAIN, KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3pvg:A    (SER51) to   (PHE181)  CRYSTAL STRUCTURE OF Z. MAYS CK2 ALPHA SUBUNIT IN COMPLEX WITH THE INHIBITOR 4,5,6,7-TETRABROMO-1-CARBOXYMETHYLBENZIMIDAZOLE (K68)  |   PROTEIN KINASE CK2-INHIBITOR COMPLEX, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4ehz:A   (GLY887) to  (THR1030)  THE JAK1 KINASE DOMAIN IN COMPLEX WITH INHIBITOR  |   KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3pwd:A    (GLU55) to   (PHE181)  CRYSTAL STRUCTURE OF MAIZE CK2 IN COMPLEX WITH NBC (Z1)  |   PROTEIN KINASE, INHIBITOR, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3py3:A    (GLY36) to   (THR175)  CRYSTAL STRUCTURE OF PHOSPHORYLATED P38ALPHA MAP KINASE  |   KINASE, TRANSFERASE, PHOSPHORYLATION 
3pzh:A    (GLU55) to   (PHE181)  CRYSTAL STRUCTURE OF MAIZE CK2 ALPHA IN COMPLEX WITH EMODIN AT 1.92 A RESOLUTION  |   PROTEIN KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3q32:A   (MET865) to  (GLN1003)  STRUCTURE OF JANUS KINASE 2 WITH A PYRROLOTRIAZINE INHIBITOR  |   ATP-BINDING, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3q32:B   (GLY861) to  (GLN1003)  STRUCTURE OF JANUS KINASE 2 WITH A PYRROLOTRIAZINE INHIBITOR  |   ATP-BINDING, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4eoj:C    (GLY16) to   (ALA151)  THR 160 PHOSPHORYLATED CDK2 H84S, Q85M, K89D - HUMAN CYCLIN A3 COMPLEX WITH ATP  |   PROTEIN KINASE, CELL CYCLE, COMPLEX, PHOSPHORYLATION, TRANSFERASE 
4eom:A    (GLY16) to   (ALA151)  THR 160 PHOSPHORYLATED CDK2 H84S, Q85M, Q131E - HUMAN CYCLIN A3 COMPLEX WITH ATP  |   PROTEIN KINASE, CELL CYCLE, COMPLEX, PHOSPHORYLATION, TRANSFERASE 
4eop:A    (GLY16) to   (ALA151)  THR 160 PHOSPHORYLATED CDK2 Q131E - HUMAN CYCLIN A3 COMPLEX WITH THE INHIBITOR RO3306  |   PROTEIN KINASE, CELL CYCLE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4eor:A    (GLY16) to   (ALA151)  THR 160 PHOSPHORYLATED CDK2 WT - HUMAN CYCLIN A3 COMPLEX WITH THE INHIBITOR NU6102  |   PROTEIN KINASE, CELL CYCLE, PHOSPHORYLATION, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4eos:C    (GLY16) to   (ALA151)  THR 160 PHOSPHORYLATED CDK2 WT - HUMAN CYCLIN A3 COMPLEX WITH THE INHIBITOR RO3306  |   PROTEIN KINASE, CELL CYCLE, PHOSPHORYLATION, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3q4z:A   (GLY282) to   (THR415)  STRUCTURE OF UNPHOSPHORYLATED PAK1 KINASE DOMAIN  |   KINASE DOMAIN, SIGNALLING PATHWAY, TRANSFERASE 
3q53:A   (GLY282) to   (THR415)  STRUCTURE OF PHOSPHORYLATED PAK1 KINASE DOMAIN IN COMPLEX WITH ATP  |   KINASE DOMAIN, SIGNALLING PATHWAY, TRANSFERASE 
5iu2:A   (GLY150) to   (GLN276)  DISCOVERY OF IMIDAZOQUINOLINES AS A NOVEL CLASS OF POTENT, SELECTIVE AND IN VIVO EFFICACIOUS COT KINASE INHIBITORS  |   COT, TPL-2, MAP3K8, KINASE, INHIBITOR, COMPLEX, TRANSFERASE 
5iu2:B   (GLY150) to   (GLN276)  DISCOVERY OF IMIDAZOQUINOLINES AS A NOVEL CLASS OF POTENT, SELECTIVE AND IN VIVO EFFICACIOUS COT KINASE INHIBITORS  |   COT, TPL-2, MAP3K8, KINASE, INHIBITOR, COMPLEX, TRANSFERASE 
4erk:A    (GLY35) to   (VAL171)  THE COMPLEX STRUCTURE OF THE MAP KINASE ERK2/OLOMOUCINE  |   TRANSFERASE, SERINE/THREONINE-PROTEIN KINASE, MAP KINASE, ERK2 
3q9y:A    (SER51) to   (PHE181)  CRYSTAL STRUCTURE OF HUMAN CK2 ALPHA IN COMPLEX WITH QUINALIZARIN AT PH 8.5  |   PROTEIN KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3q9z:A    (SER51) to   (PHE181)  CRYSTAL STRUCTURE OF HUMAN CK2 ALPHA IN COMPLEX WITH QUINALIZARIN AT PH 6.5  |   PROTEIN KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3qa0:A    (SER51) to   (PHE181)  CRYSTAL STRUCTURE OF THE APO-FORM OF HUMAN CK2 ALPHA AT PH 6.5  |   PROTEIN KINASE, APO-FORM, TRANSFERASE 
4f08:A   (GLY861) to  (GLN1003)  DISCOVERY AND OPTIMIZATION OF C-2 METHYL IMIDAZO-PYRROLOPYRIDINES AS POTENT AND ORALLY BIOAVAILABLE JAK1 INHIBITORS WITH SELECTIVITY OVER JAK2  |   JAK2, KINASE DOMAIN, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4f08:B   (GLY861) to  (GLN1003)  DISCOVERY AND OPTIMIZATION OF C-2 METHYL IMIDAZO-PYRROLOPYRIDINES AS POTENT AND ORALLY BIOAVAILABLE JAK1 INHIBITORS WITH SELECTIVITY OVER JAK2  |   JAK2, KINASE DOMAIN, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4f09:A   (GLY861) to  (GLN1003)  DISCOVERY AND OPTIMIZATION OF C-2 METHYL IMIDAZO-PYRROLOPYRIDINES AS POTENT AND ORALLY BIOAVAILABLE JAK1 INHIBITORS WITH SELECTIVITY OVER JAK2  |   JAK2, KINASE DOMAIN, JH1 DOMAIN, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4f99:A    (SER70) to   (GLY202)  HUMAN CDC7 KINASE IN COMPLEX WITH DBF4 AND NUCLEOTIDE  |   SER/THR PROTEIN KINASE, TRANSFERASE, PHOSPHORYLATION, CELL CYCLE, CELL DIVISION, MITOSIS, S PHASE, SERINE/THREONINE-PROTEIN KINASE, DBF4-DEPENDENT KINASE, DDK, ATP-BINDING, NUCLEOTIDE-BINDING, ZINC- BINDING, NUCLEUS 
4f9a:A    (SER70) to   (GLY202)  HUMAN CDC7 KINASE IN COMPLEX WITH DBF4 AND NUCLEOTIDE  |   SER/THR PROTEIN KINASE, TRANSFERASE, PHOSPHORYLATION, CELL CYCLE, CELL DIVISION, MITOSIS, S PHASE, SERINE/THREONINE-PROTEIN KINASE, DBF4-DEPENDENT KINASE, DDK, ATP-BINDING, NUCLEOTIDE-BINDING, ZINC- BINDING, NUCLEUS 
4f9a:C    (SER70) to   (GLY202)  HUMAN CDC7 KINASE IN COMPLEX WITH DBF4 AND NUCLEOTIDE  |   SER/THR PROTEIN KINASE, TRANSFERASE, PHOSPHORYLATION, CELL CYCLE, CELL DIVISION, MITOSIS, S PHASE, SERINE/THREONINE-PROTEIN KINASE, DBF4-DEPENDENT KINASE, DDK, ATP-BINDING, NUCLEOTIDE-BINDING, ZINC- BINDING, NUCLEUS 
4v0g:A   (GLY834) to   (LEU974)  JAK3 IN COMPLEX WITH A COVALENT EGFR INHIBITOR  |   TRANSFERASE, EGFR MUTANT, T790M 
4fbx:A    (SER51) to   (PHE181)  COMPLEX STRUCTURE OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT CRYSTALLIZED IN THE PRESENCE OF A BISUBSTRATE INHIBITOR  |   PROTEIN KINASE FOLD, PROTEIN PHOSPHORYLATION, BISUBSTRATE INHIBITOR, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3qyw:A    (GLY35) to   (VAL171)  CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH AN INHIBITOR  |   TRANSFERASE, SERINE/THREONINE-PROTEIN KINASE, ATP-BINDING CELL CYCLE, PHOSPHORYLATION, PROTEIN KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3qyz:A    (GLY35) to   (VAL171)  CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH AN INHIBITOR  |   TRANSFERASE, SERINE/THREONINE-PROTEIN KINASE, ATP-BINDING CELL CYCLE, PHOSPHORYLATION, PROTEIN KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4fi1:A    (SER52) to   (PHE220)  CRYSTAL STRUCTURE OF SCCK2 ALPHA IN COMPLEX WITH ATP  |   PROTEIN-ATP COMPLEX, PROTEIN KINASE, PHOSPHORYLATION, TRANSFERASE 
4fie:A   (CYS336) to   (SER466)  FULL-LENGTH HUMAN PAK4  |   SERINE/THREONINE-PROTEIN KINASE PAK4, KINASE DOMAIN, PROTEIN KINASE, ATP BINDING, PHOSPHORYLATION, TRANSFERASE 
4fie:B   (CYS336) to   (SER466)  FULL-LENGTH HUMAN PAK4  |   SERINE/THREONINE-PROTEIN KINASE PAK4, KINASE DOMAIN, PROTEIN KINASE, ATP BINDING, PHOSPHORYLATION, TRANSFERASE 
4w7p:B    (GLY88) to   (ASN224)  CRYSTAL STRUCTURE OF ROCK 1 BOUND TO YB-15-QD37  |   INHIBITOR, KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4fk6:A   (LEU891) to  (THR1030)  JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 72  |   PROTEIN KINASE, PHOSPHO TRANSFER, PHOSPHO TYROSINE, TRANSFERASE- TRANSFERASE INHIBITOR COMPLEX 
4fmq:A    (GLY37) to   (ALA174)  CRYSTAL STRUCTURE OF HUMAN ERK2 COMPLEXED WITH A MAPK DOCKING PEPTIDE  |   TRANSFERASE, SIGNALING, PROTEIN-PROTEIN INTERACTION, TRANSFERASE- SIGNALING PROTEIN COMPLEX 
4fv0:A    (GLY35) to   (VAL171)  CRYSTAL STRUCTURE OF THE ERK2 COMPLEXED WITH EK3  |   TRANSFERASE 
4fv2:A    (GLY35) to   (VAL171)  CRYSTAL STRUCTURE OF THE ERK2 COMPLEXED WITH EK5  |   TRANSFERASE 
4fv4:A    (GLY35) to   (VAL171)  CRYSTAL STRUCTURE OF THE ERK2 COMPLEXED WITH EK7  |   TRANSFERASE 
4fv6:A    (GLY35) to   (ALA172)  CRYSTAL STRUCTURE OF THE ERK2 COMPLEXED WITH E57  |   TRANSFERASE 
4fv8:A    (GLY35) to   (ALA172)  CRYSTAL STRUCTURE OF THE ERK2 COMPLEXED WITH E63  |   TRANSFERASE 
4fv9:A    (GLY35) to   (VAL171)  CRYSTAL STRUCTURE OF THE ERK2 COMPLEXED WITH E71  |   TRANSFERASE 
4g3c:B   (HIS417) to   (GLN544)  CRYSTAL STRUCTURE OF APO MURINE NF-KAPPAB INDUCING KINASE (NIK)  |   NON-RD KINASE, PROTEIN SERINE/THREONINE KINASE, NF-KAPPAB, MAP3K14, TRANSFERASE 
4g3d:A   (GLU413) to   (PRO543)  CRYSTAL STRUCTURE OF HUMAN NF-KAPPAB INDUCING KINASE (NIK)  |   NON-RD KINASE, PROTEIN SERINE/THREONINE KINASE, NF-KAPPAB, MAP3K14, TRANSFERASE 
4g3d:B   (HIS415) to   (LEU541)  CRYSTAL STRUCTURE OF HUMAN NF-KAPPAB INDUCING KINASE (NIK)  |   NON-RD KINASE, PROTEIN SERINE/THREONINE KINASE, NF-KAPPAB, MAP3K14, TRANSFERASE 
4g3d:E   (HIS415) to   (GLN542)  CRYSTAL STRUCTURE OF HUMAN NF-KAPPAB INDUCING KINASE (NIK)  |   NON-RD KINASE, PROTEIN SERINE/THREONINE KINASE, NF-KAPPAB, MAP3K14, TRANSFERASE 
4g3e:A   (HIS417) to   (CYS542)  CRYSTAL STRUCTURE OF MURINE NF-KAPPAB INDUCING KINASE (NIK) BOUND TO A 6-ALKYNYLINDOLINE (CMP1)  |   NON-RD KINASE, PROTEIN SERINE/THREONINE KINASE, NF-KAPPAB,STRUCTURE- BASED DRUG DESIGN, MAP3K14, TRANSFERASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4g3e:B   (HIS417) to   (GLN544)  CRYSTAL STRUCTURE OF MURINE NF-KAPPAB INDUCING KINASE (NIK) BOUND TO A 6-ALKYNYLINDOLINE (CMP1)  |   NON-RD KINASE, PROTEIN SERINE/THREONINE KINASE, NF-KAPPAB,STRUCTURE- BASED DRUG DESIGN, MAP3K14, TRANSFERASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4g6o:A    (GLY35) to   (VAL171)  CRYSTAL STRUCTURE OF THE ERK2  |   TRANSFERASE 
5k5n:A    (GLY68) to   (GLN206)  CRYSTAL STRUCTURE OF GSK-3BETA COMPLEXED WITH PF-04802367, A HIGHLY SELECTIVE BRAIN-PENETRANT KINASE INHIBITOR  |   PROTEIN KINASE, ALZHIMER'S DISEASE, TAU KINASE, TRANSFERASE 
5k5n:B    (GLY68) to   (GLN206)  CRYSTAL STRUCTURE OF GSK-3BETA COMPLEXED WITH PF-04802367, A HIGHLY SELECTIVE BRAIN-PENETRANT KINASE INHIBITOR  |   PROTEIN KINASE, ALZHIMER'S DISEASE, TAU KINASE, TRANSFERASE 
4gfo:A   (GLY909) to  (GLU1050)  TYK2 KINASE (JH1 DOMAIN) WITH 2,6-DICHLORO-N-(2-OXO-2,5- DIHYDROPYRIDIN-4-YL)BENZAMIDE  |   PROTEIN KINASE, PHOSPHOTRANSFER CATALYST, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4gih:A   (GLY909) to  (PRO1049)  TYK2 (JH1) IN COMPLEX WITH 2,6-DICHLORO-N-{2-[(CYCLOPROPYLCARBONYL) AMINO]PYRIDIN-4-YL}BENZAMIDE  |   TYROSINE KINASE, KINASE, ATP BINDING, INHIBITOR, TRANSFERASE- TRANSFERASE INHIBITOR COMPLEX 
4gii:A   (GLY909) to  (PRO1049)  TYK2 (JH1) IN COMPLEX WITH 2,6-DICHLORO-4-CYANO-N-{2- [(CYCLOPROPYLCARBONYL)AMINO]PYRIDIN-4-YL}BENZAMIDE  |   AMINOPYRIDINE, BENZAMIDE, KINASE, ENZYME INHIBITOR, TYROSINE KINASE, ATP BINDING, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4gj2:A   (GLY909) to  (PRO1049)  TYK2 (JH1) IN COMPLEX WITH 2,6-DICHLORO-N-[2-({[(1R,2R)-2- FLUOROCYCLOPROPYL]CARBONYL}AMINO)PYRIDIN-4-YL]BENZAMIDE  |   KINASE, ATP BINDING, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
5khw:A   (GLY887) to  (THR1030)  CRYSTAL STRUCTURE OF JAK1 IN COMPLEX WITH ADP  |   JAK1, KINASE, INHIBITOR, COMPLEX, TRANSFERASE 
5khw:B   (GLY887) to  (THR1030)  CRYSTAL STRUCTURE OF JAK1 IN COMPLEX WITH ADP  |   JAK1, KINASE, INHIBITOR, COMPLEX, TRANSFERASE 
4gl9:A   (MET865) to  (GLN1003)  CRYSTAL STRUCTURE OF INHIBITORY PROTEIN SOCS3 IN COMPLEX WITH JAK2 KINASE DOMAIN AND FRAGMENT OF GP130 INTRACELLULAR DOMAIN  |   KINASE INHIBITOR RECEPTOR CYTOKINE SIGNALLING, PHOSPHORYLATION, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4gl9:C   (MET865) to  (GLN1003)  CRYSTAL STRUCTURE OF INHIBITORY PROTEIN SOCS3 IN COMPLEX WITH JAK2 KINASE DOMAIN AND FRAGMENT OF GP130 INTRACELLULAR DOMAIN  |   KINASE INHIBITOR RECEPTOR CYTOKINE SIGNALLING, PHOSPHORYLATION, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4gl9:D   (MET865) to  (GLN1003)  CRYSTAL STRUCTURE OF INHIBITORY PROTEIN SOCS3 IN COMPLEX WITH JAK2 KINASE DOMAIN AND FRAGMENT OF GP130 INTRACELLULAR DOMAIN  |   KINASE INHIBITOR RECEPTOR CYTOKINE SIGNALLING, PHOSPHORYLATION, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4grb:A    (GLU55) to   (PHE181)  CASEIN KINASE 2 (CK2) BOUND TO INHIBITOR  |   KINASE, PROTEIN KINASE, CYTOSOL, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
5kx8:C   (GLY198) to   (SER336)  IRAK4-INHIBITOR CO-STRUCTURE  |   KINASE, PHOSPHATASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
5kx8:D   (GLY198) to   (SER336)  IRAK4-INHIBITOR CO-STRUCTURE  |   KINASE, PHOSPHATASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
5l3a:A   (GLY861) to  (GLN1003)  FRAGMENT-BASED DISCOVERY OF 6-ARYLINDAZOLE JAK INHIBITORS  |   DOUBLE F MUTANT, TRANSFERASE 
5l6w:L   (PHE350) to   (MET485)  STRUCTURE OF THE LIMK1-ATPGAMMAS-CFL1 COMPLEX  |   KINASE COMPLEX, TRANSFERASE 
5lcj:A    (GLY37) to   (VAL173)  IN-GEL ACTIVITY-BASED PROTEIN PROFILING OF A CLICKABLE COVALENT ERK 1/2 INHIBITOR  |   ERK1/2 COVALENT INHIBITOR, TRANSFERASE 
5lpy:A   (GLY895) to  (SER1035)  CRYSTAL STRUCTURE OF THE BRI1 KINASE DOMAIN (865-1160) IN COMPLEX WITH ATP FROM ARABIDOPSIS THALIANA  |   BRASSINOSTEROID RECEPTOR, KINASE DOMAIN, DUAL-SPECIFICIFY KINASE, MEMBRANE RECEPTOR KINASE, PLASMA MEMBRANE, TRANSFERASE 
5lpz:A   (GLY895) to  (SER1035)  CRYSTAL STRUCTURE OF THE BRI1 KINASE DOMAIN (865-1196) IN COMPLEX WITH ADP FROM ARABIDOPSIS THALIANA  |   BRASSINOSTEROID RECEPTOR, KINASE DOMAIN, DUAL-SPECIFICIFY KINASE, MEMBRANE RECEPTOR KINASE, PLASMA MEMBRANE, TRANSFERASE 
5lwm:A   (GLY834) to   (LEU976)  CRYSTAL STRUCTURE OF JAK3 IN COMPLEX WITH COMPOUND 4 (FM381)  |   TRANSFERASE, KINASE, JAK3, COVALENT INHIBITOR, REVERSIBLE COVALENT INHIBITOR, INDUCED POCKET, ARGININE POCKET, STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC 
5toz:A   (PHE833) to   (LEU976)  JAK3 WITH COVALENT INHIBITOR PF-06651600  |   JAK3 COVALENT KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3eb0:A    (PHE20) to   (LYS191)  CRYSTAL STRUCTURE OF CGD4_240 FROM CRYPTOSPORIDIUM PARVUM IN COMPLEX WITH INDIRUBIN E804  |   KINASE CRYPTOSPORIDIUM PARVUM, ATP-BINDING, KINASE, NUCLEOTIDE- BINDING, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE, UNKNOWN FUNCTION, STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC 
3eb0:C    (PHE20) to   (LYS191)  CRYSTAL STRUCTURE OF CGD4_240 FROM CRYPTOSPORIDIUM PARVUM IN COMPLEX WITH INDIRUBIN E804  |   KINASE CRYPTOSPORIDIUM PARVUM, ATP-BINDING, KINASE, NUCLEOTIDE- BINDING, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE, UNKNOWN FUNCTION, STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC 
2oib:A   (GLY198) to   (GLU337)  CRYSTAL STRUCTURE OF IRAK4 KINASE DOMAIN APO FORM  |   KINASE, HELIC C, TRANSFERASE 
2oib:B   (GLY198) to   (SER336)  CRYSTAL STRUCTURE OF IRAK4 KINASE DOMAIN APO FORM  |   KINASE, HELIC C, TRANSFERASE 
2oib:D   (GLY198) to   (GLU337)  CRYSTAL STRUCTURE OF IRAK4 KINASE DOMAIN APO FORM  |   KINASE, HELIC C, TRANSFERASE 
3rvg:A   (GLY861) to  (GLN1003)  CRYSTALS STRUCTURE OF JAK2 WITH A 1-AMINO-5H-PYRIDO[4,3-B]INDOL-4- CARBOXAMIDE INHIBITOR  |   TYROSINE KINASE, JANUS KINASE 2, ENZYME INHIBITORS, TRANSFERASE- TRANSFERASE INHIBITOR COMPLEX 
2oxx:A    (SER51) to   (PHE181)  PROTEIN KINASE CK2 IN COMPLEX WITH TETRABROMOBENZOIMIDAZOLE DERIVATIVES K17, K22 AND K32  |   PROTEIN KINASE CK2, INHIBITORS, TETRABROMOBENZOIMIDAZOLE DERIVATIVES, TRANSFERASE 
1nxk:A    (LEU79) to   (THR215)  CRYSTAL STRUCTURE OF STAUROSPORINE BOUND TO MAP KAP KINASE 2  |   PROTEIN KINASE, MK2, PHOSPHORYLATION, STAUROSPORINE, TRANSFERASE 
1nxk:B    (LEU79) to   (THR215)  CRYSTAL STRUCTURE OF STAUROSPORINE BOUND TO MAP KAP KINASE 2  |   PROTEIN KINASE, MK2, PHOSPHORYLATION, STAUROSPORINE, TRANSFERASE 
3eyh:A   (LEU891) to  (THR1030)  CRYSTAL STRUCTURES OF JAK1 AND JAK2 INHIBITOR COMPLEXES  |   JAK KINASE, ATP-BINDING, KINASE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SH2 DOMAIN, TRANSFERASE, TYROSINE-PROTEIN KINASE 
2pk9:A    (ALA19) to   (GLY159)  STRUCTURE OF THE PHO85-PHO80 CDK-CYCLIN COMPLEX OF THE PHOSPHATE-RESPONSIVE SIGNAL TRANSDUCTION PATHWAY  |   CYCLIN-DEPENDENT KINASE, CYCLIN, SIGNALING PROTEIN, TRANSFERASE/ CELL CYCLE COMPLEX, SIGNALING PROTEIN, TRANSFERASE/CELL CYCLE COMPLEX 
2pk9:C    (THR20) to   (GLY159)  STRUCTURE OF THE PHO85-PHO80 CDK-CYCLIN COMPLEX OF THE PHOSPHATE-RESPONSIVE SIGNAL TRANSDUCTION PATHWAY  |   CYCLIN-DEPENDENT KINASE, CYCLIN, SIGNALING PROTEIN, TRANSFERASE/ CELL CYCLE COMPLEX, SIGNALING PROTEIN, TRANSFERASE/CELL CYCLE COMPLEX 
2pvm:A    (SER51) to   (PHE181)  STRUCTURE-BASED DESIGN OF PYRAZOLO[1,5-A][1,3,5]TRIAZINE DERIVATIVES AS POTENT INHIBITORS OF PROTEIN KINASE CK2  |   STRUCTURE-BASED DRUG DESIGN, ENZYME-INHIBITOR COMPLEX, CASEIN KINASE II, PROTEIN KINASE CK2, TRANSFERASE 
3fup:A   (GLY861) to  (GLN1003)  CRYSTAL STRUCTURES OF JAK1 AND JAK2 INHIBITOR COMPLEXES  |   KINASE, PTK DOMAIN, PROTEIN-INHIBITOR COMPLEX, ATP-BINDING, CHROMOSOMAL REARRANGEMENT, DISEASE MUTATION, MEMBRANE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, POLYMORPHISM, PROTO- ONCOGENE, SH2 DOMAIN, TRANSFERASE, TYROSINE-PROTEIN KINASE 
3fup:B   (THR875) to  (GLN1003)  CRYSTAL STRUCTURES OF JAK1 AND JAK2 INHIBITOR COMPLEXES  |   KINASE, PTK DOMAIN, PROTEIN-INHIBITOR COMPLEX, ATP-BINDING, CHROMOSOMAL REARRANGEMENT, DISEASE MUTATION, MEMBRANE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, POLYMORPHISM, PROTO- ONCOGENE, SH2 DOMAIN, TRANSFERASE, TYROSINE-PROTEIN KINASE 
3fyk:X    (LEU79) to   (THR215)  CRYSTAL STRUCTURE OF A BENZTHIOPHENE LEAD BOUND TO MAPKAP KINASE-2 (MK-2)  |   MK-2, MK2, MAPKAP-2, SER/THR KINASE, MAP KINASE, ALTERNATIVE SPLICING, ATP-BINDING, KINASE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, POLYMORPHISM, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE 
4xp2:A    (GLY35) to   (VAL171)  CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH AN INHIBITOR  |   SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE 
4xs2:A   (PHE197) to   (SER336)  IRAK4-INHIBITOR CO-STRUCTURE  |   KINASE, PHOSPHATASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4xs2:D   (GLY198) to   (SER336)  IRAK4-INHIBITOR CO-STRUCTURE  |   KINASE, PHOSPHATASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4imy:C    (GLU32) to   (ALA173)  THE AFF4 SCAFFOLD BINDS HUMAN P-TEFB ADJACENT TO HIV TAT  |   TRANSCRIPTIONAL CDK9-CYCT1 COMPLEX, PHOSPHORYLATED, INTRINSICALLY DISORDERED AFF4, REGULATION OF TRANSCRIPTION ELONGATION, SER/THR KINASE, PHOSPHORYLATION OF POLII-CTD, DSIF, AND NELF, HIV-1 TAT, HOST-VIRUS INTERACTION, PHOSPHOPROTEIN, NUCLEUS, TRANSFERASE 
1phk:A    (ARG35) to   (GLN173)  TWO STRUCTURES OF THE CATALYTIC DOMAIN OF PHOSPHORYLASE, KINASE: AN ACTIVE PROTEIN KINASE COMPLEXED WITH NUCLEOTIDE, SUBSTRATE-ANALOGUE AND PRODUCT  |   GLYCOGEN METABOLISM, TRANSFERASE, SERINE/THREONINE-PROTEIN, KINASE, ATP-BINDING, CALMODULIN-BINDING 
4ivc:A   (GLY887) to  (THR1030)  JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH THE INHIBITOR (TRANS-4-{2- [(1R)-1-HYDROXYETHYL]IMIDAZO[4,5-D]PYRROLO[2,3-B]PYRIDIN-1(6H)- YL}CYCLOHEXYL)ACETONITRILE  |   PROTEIN KINASE, PHOSPHO TRANSFER, PHOSPHO TYROSINE, TRANSFERASE- TRANSFERASE INHIBITOR COMPLEX, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4jia:A   (GLY861) to  (PRO1002)  JAK2 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 9  |   PROTEIN KINASE, PHOSPHOTRANSFER, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3u4u:A    (SER51) to   (PHE181)  CASEIN KINASE 2 IN COMPLEX WITH AZ-INHIBITOR  |   KINASE, TRANSFERASE, INHIBITOR BINDING, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3u9c:A    (SER51) to   (PHE181)  STRUCTURE OF A C-TERMINAL DELETION MUTANT OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT WITH THE ATP-COMPETITIVE INHIBITOR RESORUFIN  |   PROTEIN KINASE CK2 CASEIN KINASE 2, EUKARYOTIC PROTEIN KINASE FOLD, ATP:PROTEIN PHOSPHOTRANSFERASE, PROTEIN KINASE, ATP CK2BETA, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3u9c:B    (SER51) to   (PHE181)  STRUCTURE OF A C-TERMINAL DELETION MUTANT OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT WITH THE ATP-COMPETITIVE INHIBITOR RESORUFIN  |   PROTEIN KINASE CK2 CASEIN KINASE 2, EUKARYOTIC PROTEIN KINASE FOLD, ATP:PROTEIN PHOSPHOTRANSFERASE, PROTEIN KINASE, ATP CK2BETA, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
2eu9:A   (GLY168) to   (ASP327)  CRYSTAL STRUCTURE OF CLK3  |   KINASE DOMAIN, TRANSFERASE 
4yti:A   (PHE860) to  (GLN1003)  DISCOVERY OF VX-509 (DECERNOTINIB): A POTENT AND SELECTIVE JANUS KINASE (JAK) 3 INHIBITOR FOR THE TREATMENT OF AUTOIMMUNE DISEASE  |   JANUS KINASE, JAK2, JAK3, KINASE, INHIBITOR, AUTOIMMUNE, TRANSFERASE- TRANSFERASE INHIBITOR COMPLEX 
2f9g:A    (GLY25) to   (ILE161)  CRYSTAL STRUCTURE OF FUS3 PHOSPHORYLATED ON TYR182  |   MAP KINASE, TRANSFERASE 
3i60:A    (GLY35) to   (ALA172)  CRYSTAL STRUCTURE OF ERK2 BOUND TO (S)-4-(2-(2-CHLOROPHENYLAMINO)-5- METHYLPYRIMIDIN-4-YL)-N-(2-HYDROXY-1-PHENYLETHYL)-1H-PYRROLE-2- CARBOXAMIDE  |   KINASE, INHIBITOR, ATP-BINDING, CELL CYCLE, HOST-VIRUS INTERACTION, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE 
2vx3:C   (GLY171) to   (GLN313)  CRYSTAL STRUCTURE OF THE HUMAN DUAL SPECIFICITY TYROSINE- PHOSPHORYLATION-REGULATED KINASE 1A  |   SERINE/THREONINE-PROTEIN KINASE, MINIBRAIN HOMOLOG, NUCLEOTIDE-BINDING, TRANSFERASE, PHOSPHOPROTEIN, TYROSINE-PROTEIN KINASE, CASP8, KINASE 
2gph:A    (GLY35) to   (VAL171)  DOCKING MOTIF INTERACTIONS IN THE MAP KINASE ERK2  |   ERK2, DOCKING INTERACTION, D-MOTIF, ALLOSTERY, CD-SITE, PHOSPHATASE-DERIVED PEPTIDE, PROCESSING CONFORMATION, TRANSFERASE 
3iok:A   (GLY861) to  (GLN1003)  2-AMINOPYRAZOLO[1,5-A]PYRIMIDINES AS POTENT AND SELECTIVE INHIBITORS OF JAK2  |   KINASE, INHIBITOR, JAK2, JANUS KINASE, ATP-BINDING, DISEASE MUTATION, MEMBRANE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, PROTO-ONCOGENE, SH2 DOMAIN, TRANSFERASE, TYROSINE-PROTEIN KINASE 
2wip:A    (GLY27) to   (GLY153)  STRUCTURE OF CDK2-CYCLIN A COMPLEXED WITH 8-ANILINO-1- METHYL-4,5-DIHYDRO-1H-PYRAZOLO[4,3-H] QUINAZOLINE-3- CARBOXYLIC ACID  |   CELL CYCLE, ATP-BINDING, TRANSFERASE, POLYMORPHISM, PHOSPHORYLATION, NUCLEOTIDE-BINDING, SERINE/THREONINE-PROTEIN 2 KINASE, SERINE/THREONINE-PROTEIN KINASE, CELL DIVISION, PHOSPHOPROTEIN, PROTEIN KINASE, KINASE, CYCLIN, NUCLEUS, MITOSIS, CYTOPLASM 
2wip:C    (VAL17) to   (GLY153)  STRUCTURE OF CDK2-CYCLIN A COMPLEXED WITH 8-ANILINO-1- METHYL-4,5-DIHYDRO-1H-PYRAZOLO[4,3-H] QUINAZOLINE-3- CARBOXYLIC ACID  |   CELL CYCLE, ATP-BINDING, TRANSFERASE, POLYMORPHISM, PHOSPHORYLATION, NUCLEOTIDE-BINDING, SERINE/THREONINE-PROTEIN 2 KINASE, SERINE/THREONINE-PROTEIN KINASE, CELL DIVISION, PHOSPHOPROTEIN, PROTEIN KINASE, KINASE, CYCLIN, NUCLEUS, MITOSIS, CYTOPLASM 
5a4l:B   (GLY171) to   (LEU314)  DYRK1A IN COMPLEX WITH FLUORO BENZOTHIAZOLE FRAGMENT  |   TRANSFERASE 
4md9:E    (SER51) to   (PHE181)  CRYSTAL STRUCTURE OF SYMMETRIC CK2 HOLOENZYME WITH MUTATED ALPHA SUBUNIT (F121E TRUNCATED AT AA 336)  |   PROTEIN SERINE/THREONINE KINASE, TRANSFERASE 
4md9:F    (GLU55) to   (PHE181)  CRYSTAL STRUCTURE OF SYMMETRIC CK2 HOLOENZYME WITH MUTATED ALPHA SUBUNIT (F121E TRUNCATED AT AA 336)  |   PROTEIN SERINE/THREONINE KINASE, TRANSFERASE 
4md9:H    (SER51) to   (PHE181)  CRYSTAL STRUCTURE OF SYMMETRIC CK2 HOLOENZYME WITH MUTATED ALPHA SUBUNIT (F121E TRUNCATED AT AA 336)  |   PROTEIN SERINE/THREONINE KINASE, TRANSFERASE 
4md9:L    (SER51) to   (PHE181)  CRYSTAL STRUCTURE OF SYMMETRIC CK2 HOLOENZYME WITH MUTATED ALPHA SUBUNIT (F121E TRUNCATED AT AA 336)  |   PROTEIN SERINE/THREONINE KINASE, TRANSFERASE 
4md9:P    (GLU55) to   (PHE181)  CRYSTAL STRUCTURE OF SYMMETRIC CK2 HOLOENZYME WITH MUTATED ALPHA SUBUNIT (F121E TRUNCATED AT AA 336)  |   PROTEIN SERINE/THREONINE KINASE, TRANSFERASE 
4n4s:A    (GLY35) to   (ALA172)  A DOUBLE MUTANT RAT ERK2 IN COMPLEX WITH A PYRAZOLO[3,4-D]PYRIMIDINE INHIBITOR  |   SERINE/THREONINE KINASE, MAP KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4n4s:B    (GLY35) to   (ALA172)  A DOUBLE MUTANT RAT ERK2 IN COMPLEX WITH A PYRAZOLO[3,4-D]PYRIMIDINE INHIBITOR  |   SERINE/THREONINE KINASE, MAP KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3zep:A   (SER835) to   (LEU976)  CRYSTAL STRUCTURE OF JAK3 KINASE DOMAIN IN COMPLEX WITH A PYRROLOPYRAZINE-2-PHENYL ETHER INHIBITOR  |   TRANSFERASE, STAT5, STAT6, INTERLEUKIN-2, COMMON-GAMMA CHAIN, ATP SITE KINASE INHIBITOR, CANCER, SCID, SEVERE COMBINED IMMUNODEFICIENCY 
3zep:D   (SER835) to   (LEU976)  CRYSTAL STRUCTURE OF JAK3 KINASE DOMAIN IN COMPLEX WITH A PYRROLOPYRAZINE-2-PHENYL ETHER INHIBITOR  |   TRANSFERASE, STAT5, STAT6, INTERLEUKIN-2, COMMON-GAMMA CHAIN, ATP SITE KINASE INHIBITOR, CANCER, SCID, SEVERE COMBINED IMMUNODEFICIENCY 
5bue:A    (GLY35) to   (ALA172)  ERK2 COMPLEXED WITH N-BENZYLPYRIDONE TETRAHYDROAZAINDAZOLE  |   ERK KINASE, ATP INHIBITOR, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3kc3:B    (ASN75) to   (THR215)  MK2 COMPLEXED TO INHIBITOR N4-(7-(BENZOFURAN-2-YL)-1H-INDAZOL-5-YL) PYRIMIDINE-2,4-DIAMINE  |   MAPKAP-K2, MK2, TNFALPHA, DIAMINOPYRIMIDINE, ATP-BINDING, KINASE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE 
3kc3:D    (ASN75) to   (THR214)  MK2 COMPLEXED TO INHIBITOR N4-(7-(BENZOFURAN-2-YL)-1H-INDAZOL-5-YL) PYRIMIDINE-2,4-DIAMINE  |   MAPKAP-K2, MK2, TNFALPHA, DIAMINOPYRIMIDINE, ATP-BINDING, KINASE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE 
3kc3:E    (LYS77) to   (THR215)  MK2 COMPLEXED TO INHIBITOR N4-(7-(BENZOFURAN-2-YL)-1H-INDAZOL-5-YL) PYRIMIDINE-2,4-DIAMINE  |   MAPKAP-K2, MK2, TNFALPHA, DIAMINOPYRIMIDINE, ATP-BINDING, KINASE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE 
3kc3:F    (LYS77) to   (THR214)  MK2 COMPLEXED TO INHIBITOR N4-(7-(BENZOFURAN-2-YL)-1H-INDAZOL-5-YL) PYRIMIDINE-2,4-DIAMINE  |   MAPKAP-K2, MK2, TNFALPHA, DIAMINOPYRIMIDINE, ATP-BINDING, KINASE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE 
3kc3:H    (LEU79) to   (THR215)  MK2 COMPLEXED TO INHIBITOR N4-(7-(BENZOFURAN-2-YL)-1H-INDAZOL-5-YL) PYRIMIDINE-2,4-DIAMINE  |   MAPKAP-K2, MK2, TNFALPHA, DIAMINOPYRIMIDINE, ATP-BINDING, KINASE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE 
3kc3:J    (LYS77) to   (THR215)  MK2 COMPLEXED TO INHIBITOR N4-(7-(BENZOFURAN-2-YL)-1H-INDAZOL-5-YL) PYRIMIDINE-2,4-DIAMINE  |   MAPKAP-K2, MK2, TNFALPHA, DIAMINOPYRIMIDINE, ATP-BINDING, KINASE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE 
3kc3:L    (GLY76) to   (THR214)  MK2 COMPLEXED TO INHIBITOR N4-(7-(BENZOFURAN-2-YL)-1H-INDAZOL-5-YL) PYRIMIDINE-2,4-DIAMINE  |   MAPKAP-K2, MK2, TNFALPHA, DIAMINOPYRIMIDINE, ATP-BINDING, KINASE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE 
5ctp:A    (GLU55) to   (PHE181)  CRYSTAL STRUCTURE OF CK2ALPHA WITH N-(3-(3-CHLORO-4-(PHENYL) BENZYLAMINO)PROPYL)ACETAMIDE BOUND  |   CK2ALPHA, CK2A, FRAGMENT BASED DRUG DISCOVERY, HIGH CONCENTRATION SCREENING, SELECTIVE ATP COMPETITIVE INHIBITORS, SURFACE ENTROPHY REDUCTION, TRANSFERASE 
5cu0:A    (SER51) to   (PHE181)  CRYSTAL STRUCTURE OF CK2ALPHA WITH 2-HYDROXY-5-METHYLBENZOIC ACID AND N-(3-(3-CHLORO-4-(PHENYL)BENZYLAMINO)PROPYL)ACETAMIDE BOUND  |   CK2ALPHA, CK2A, FRAGMENT BASED DRUG DISCOVERY, HIGH CONCENTRATION SCREENING, SELECTIVE ATP COMPETITIVE INHIBITORS, SURFACE ENTROPHY REDUCTION, TRANSFERASE 
5cu0:B    (SER51) to   (PHE181)  CRYSTAL STRUCTURE OF CK2ALPHA WITH 2-HYDROXY-5-METHYLBENZOIC ACID AND N-(3-(3-CHLORO-4-(PHENYL)BENZYLAMINO)PROPYL)ACETAMIDE BOUND  |   CK2ALPHA, CK2A, FRAGMENT BASED DRUG DISCOVERY, HIGH CONCENTRATION SCREENING, SELECTIVE ATP COMPETITIVE INHIBITORS, SURFACE ENTROPHY REDUCTION, TRANSFERASE 
3a2c:A    (LEU79) to   (THR215)  CRYSTAL STRUCTURE OF A PYRAZOLOPYRIMIDINE INHIBITOR COMPLEX BOUND TO MAPKAP KINASE-2 (MK2)  |   GLY-RICH LOOP FORMED, AIPHA-HELIX, ALTERNATIVE SPLICING, ATP-BINDING, KINASE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, POLYMORPHISM, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE 
3a2c:B    (LEU79) to   (THR215)  CRYSTAL STRUCTURE OF A PYRAZOLOPYRIMIDINE INHIBITOR COMPLEX BOUND TO MAPKAP KINASE-2 (MK2)  |   GLY-RICH LOOP FORMED, AIPHA-HELIX, ALTERNATIVE SPLICING, ATP-BINDING, KINASE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, POLYMORPHISM, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE 
3a2c:C    (LEU79) to   (THR215)  CRYSTAL STRUCTURE OF A PYRAZOLOPYRIMIDINE INHIBITOR COMPLEX BOUND TO MAPKAP KINASE-2 (MK2)  |   GLY-RICH LOOP FORMED, AIPHA-HELIX, ALTERNATIVE SPLICING, ATP-BINDING, KINASE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, POLYMORPHISM, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE 
3a2c:F    (LEU79) to   (THR215)  CRYSTAL STRUCTURE OF A PYRAZOLOPYRIMIDINE INHIBITOR COMPLEX BOUND TO MAPKAP KINASE-2 (MK2)  |   GLY-RICH LOOP FORMED, AIPHA-HELIX, ALTERNATIVE SPLICING, ATP-BINDING, KINASE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, POLYMORPHISM, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE 
3a2c:I    (LEU79) to   (THR215)  CRYSTAL STRUCTURE OF A PYRAZOLOPYRIMIDINE INHIBITOR COMPLEX BOUND TO MAPKAP KINASE-2 (MK2)  |   GLY-RICH LOOP FORMED, AIPHA-HELIX, ALTERNATIVE SPLICING, ATP-BINDING, KINASE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, POLYMORPHISM, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE 
3a2c:J    (LEU79) to   (THR215)  CRYSTAL STRUCTURE OF A PYRAZOLOPYRIMIDINE INHIBITOR COMPLEX BOUND TO MAPKAP KINASE-2 (MK2)  |   GLY-RICH LOOP FORMED, AIPHA-HELIX, ALTERNATIVE SPLICING, ATP-BINDING, KINASE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, POLYMORPHISM, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE 
3a2c:L    (LEU79) to   (THR215)  CRYSTAL STRUCTURE OF A PYRAZOLOPYRIMIDINE INHIBITOR COMPLEX BOUND TO MAPKAP KINASE-2 (MK2)  |   GLY-RICH LOOP FORMED, AIPHA-HELIX, ALTERNATIVE SPLICING, ATP-BINDING, KINASE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, POLYMORPHISM, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE 
4app:A   (GLY333) to   (SER466)  CRYSTAL STRUCTURE OF THE HUMAN P21-ACTIVATED KINASE 4 IN COMPLEX WITH (S)-N-(5-(3-BENZYL-1-METHYLPIPERAZINE-4- CARBONYL)-6,6-DIMETHYL-1,4,5,6-TETRAHYDROPYRROLO(3,4-C) PYRAZOL-3-YL)-3-PHENOXYBENZAMIDE  |   TRANSFERASE, PROTEIN KINASE 
4aqc:A   (PHE860) to  (GLN1003)  TRIAZOLOPYRIDINE-BASED INHIBITOR OF JANUS KINASE 2  |   TRANSFERASE, ATP-BINDING 
4azf:A   (GLN162) to   (TYR301)  HUMAN DYRK2 IN COMPLEX WITH LEUCETTINE L41  |   TRANSFERASE 
3lxk:A   (GLY834) to   (LEU976)  STRUCTURAL AND THERMODYNAMIC CHARACTERIZATION OF THE TYK2 AND JAK3 KINASE DOMAINS IN COMPLEX WITH CP-690550 AND CMP-6  |   TYK2, JAK3, INFLAMMATION, CANCER, PAN INHIBITOR, ATP-BINDING, DISEASE MUTATION, KINASE, MEMBRANE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SCID, SH2 DOMAIN, TRANSFERASE, TYROSINE-PROTEIN KINASE 
4b7t:A    (GLY68) to   (GLN206)  GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH AXIN PEPTIDE AND LEUCETTINE L4  |   TRANSFERASE-PEPTIDE COMPLEX, TRANSFERASE, INSULIN PATHWAY, WNT SIGNALING PATHWAY, INHIBITOR 
3mb7:A    (SER51) to   (PHE181)  HUMAN CK2 CATALYTIC DOMAIN IN COMPLEX WITH A DIFURANE DERIVATIVE INHIBITOR (AMR)  |   KINASES, DIFURANE, INHIBITOR, CK2, ATP-BINDING, KINASE, NUCLEOTIDE- BINDING, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE 
4bbf:A   (GLY861) to  (LEU1001)  AMINOALKYLPYRIMIDINE INHIBITOR COMPLEXES WITH JAK2  |   TRANSFERASE, INHIBITOR 
4bbf:B   (GLY861) to  (GLN1003)  AMINOALKYLPYRIMIDINE INHIBITOR COMPLEXES WITH JAK2  |   TRANSFERASE, INHIBITOR 
4bbf:C   (GLY861) to  (GLN1003)  AMINOALKYLPYRIMIDINE INHIBITOR COMPLEXES WITH JAK2  |   TRANSFERASE, INHIBITOR 
4bbf:D   (GLY861) to  (LEU1001)  AMINOALKYLPYRIMIDINE INHIBITOR COMPLEXES WITH JAK2  |   TRANSFERASE, INHIBITOR 
4qmt:A    (GLY36) to   (THR170)  MST3 IN COMPLEX WITH HESPERADIN  |   PROTEIN KINASE, MST3, STK24, STERILE 20-LIKE KINASE, ATP-BINDING, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SERINE/THREONINE-TRANSFERASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4bco:A    (VAL17) to   (ALA151)  STRUCTURE OF CDK2 IN COMPLEX WITH CYCLIN A AND A 2-AMINO-4- HETEROARYL-PYRIMIDINE INHIBITOR  |   TRANSFERASE-CELL CYCLE COMPLEX, CDK-CYCLIN COMPLEX, CYCLIN-INHIBITOR, STRUCTURE-BASED DRUG DESIGN 
4qp7:B    (GLY37) to   (VAL173)  CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH 2-(1H-PYRAZOL-4-YL)-5H- PYRROLO[2,3-B]PYRAZINE  |   KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3be9:A    (GLU55) to   (PHE181)  STRUCTURE-BASED DESIGN AND SYNTHESIS OF NOVEL MACROCYCLIC PYRAZOLO[1,5-A] [1,3,5]TRIAZINE COMPOUNDS AS POTENT INHIBITORS OF PROTEIN KINASE CK2 AND THEIR ANTICANCER ACTIVITIES  |   STRUCTURE-BASED DRUG DESIGN, ENZYME-INHIBITOR COMPLEX, CASEIN KINASE II, PROTEIN KINASE CK2, ATP-BINDING, NUCLEOTIDE-BINDING, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE 
4bgq:A    (GLY25) to   (SER161)  CRYSTAL STRUCTURE OF THE HUMAN CDKL5 KINASE DOMAIN  |   TRANSFERASE, PHOSPHO-MIMETIC, KINASE 
3c9w:A    (GLY35) to   (VAL171)  CRYSTAL STRUCTURE OF ERK-2 WITH HYPOTHEMYCIN COVALENTLY BOUND  |   ERK, ACETYLATION, ATP-BINDING, CELL CYCLE, KINASE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SERINE/THREONINE- PROTEIN KINASE, TRANSFERASE 
3c9w:B    (GLY35) to   (VAL171)  CRYSTAL STRUCTURE OF ERK-2 WITH HYPOTHEMYCIN COVALENTLY BOUND  |   ERK, ACETYLATION, ATP-BINDING, CELL CYCLE, KINASE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SERINE/THREONINE- PROTEIN KINASE, TRANSFERASE 
4rio:A   (GLY834) to   (LEU976)  CRYSTAL STRUCTURE OF JAK3 KINASE DOMAIN IN COMPLEX WITH A PYRROLOPYRIDAZINE CARBOXAMIDE INHIBITOR  |   TRANSFERASE, TRANSFERASE-INHIBITOR COMPLEX 
3o71:A    (GLY35) to   (ALA172)  CRYSTAL STRUCTURE OF ERK2/DCC PEPTIDE COMPLEX  |   PROTEIN-PEPTIDE COMPLEX, KINASE, DCC, TRANSFERASE-PROTEIN BINDING COMPLEX 
4d1s:A   (PHE860) to  (GLN1003)  PYRROLE-3-CARBOXAMIDES AS POTENT AND SELECTIVE JAK2 INHIBITORS  |   TRANSFERASE, KINASE, JAK2, DRUG DISCOVERY, PROTEIN KINASE INHIBITORS, STRUCTURE-ACTIVITY RELATIONSHIP, POLYCYTHEMIA VERA, TUMOUR CELL PROLIFERATION INHIBITION, ANTI-CANCER AGENTS 
5hez:A   (MET865) to  (GLN1003)  JAK2 KINASE (JH1 DOMAIN) MUTANT P1057A IN COMPLEX WITH TG101209  |   PROTEIN KINASE, INHIBITOR, MUTATION, TYK2, SURROGATE, P1104A, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
5hez:B   (GLY861) to  (GLN1003)  JAK2 KINASE (JH1 DOMAIN) MUTANT P1057A IN COMPLEX WITH TG101209  |   PROTEIN KINASE, INHIBITOR, MUTATION, TYK2, SURROGATE, P1104A, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
5hez:C   (GLY861) to  (GLN1003)  JAK2 KINASE (JH1 DOMAIN) MUTANT P1057A IN COMPLEX WITH TG101209  |   PROTEIN KINASE, INHIBITOR, MUTATION, TYK2, SURROGATE, P1104A, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
5hez:D   (GLY861) to  (GLN1003)  JAK2 KINASE (JH1 DOMAIN) MUTANT P1057A IN COMPLEX WITH TG101209  |   PROTEIN KINASE, INHIBITOR, MUTATION, TYK2, SURROGATE, P1104A, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3oz6:A    (ILE24) to   (VAL160)  CRYSTAL STRUCTURE OF MAPK FROM CRYPTOSPORIDIUM PARVUM, CGD2_1960  |   STRUCTURAL GENOMICS CONSORTIUM, SGC, KINASE, TRANSFERASE 
3oz6:B    (GLY23) to   (VAL160)  CRYSTAL STRUCTURE OF MAPK FROM CRYPTOSPORIDIUM PARVUM, CGD2_1960  |   STRUCTURAL GENOMICS CONSORTIUM, SGC, KINASE, TRANSFERASE 
4dgn:A    (SER51) to   (PHE181)  CRYSTAL STRUCTURE OF MAIZE CK2 IN COMPLEX WITH THE INHIBITOR LUTEOLIN  |   PROTEIN KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4e6d:A   (GLY861) to  (GLN1003)  JAK2 KINASE (JH1 DOMAIN) TRIPLE MUTANT IN COMPLEX WITH COMPOUND 7  |   JAK2, KINASE, TRANSFERASE, PHOSPHORYLATION, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4e6d:B   (GLY861) to  (GLN1003)  JAK2 KINASE (JH1 DOMAIN) TRIPLE MUTANT IN COMPLEX WITH COMPOUND 7  |   JAK2, KINASE, TRANSFERASE, PHOSPHORYLATION, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4e6q:A   (GLY861) to  (PRO1002)  JAK2 KINASE (JH1 DOMAIN) TRIPLE MUTANT IN COMPLEX WITH COMPOUND 12  |   JAK2, KINASE DOMAIN, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4e6q:B   (GLY861) to  (GLN1003)  JAK2 KINASE (JH1 DOMAIN) TRIPLE MUTANT IN COMPLEX WITH COMPOUND 12  |   JAK2, KINASE DOMAIN, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3q9x:A    (SER51) to   (PHE181)  CRYSTAL STRUCTURE OF HUMAN CK2 ALPHA IN COMPLEX WITH EMODIN AT PH 6.5  |   PROTEIN KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4f9b:A    (SER70) to   (GLY202)  HUMAN CDC7 KINASE IN COMPLEX WITH DBF4 AND PHA767491  |   SER/THR PROTEIN KINASE, TRANSFERASE, PHOSPHORYLATION, CELL CYCLE, CELL DIVISION, MITOSIS, S PHASE, SERINE/THREONINE-PROTEIN KINASE, DBF4-DEPENDENT KINASE, DDK, ATP-BINDING, NUCLEOTIDE-BINDING, ZINC- BINDING, NUCLEUS, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4f9b:C    (SER70) to   (THR203)  HUMAN CDC7 KINASE IN COMPLEX WITH DBF4 AND PHA767491  |   SER/THR PROTEIN KINASE, TRANSFERASE, PHOSPHORYLATION, CELL CYCLE, CELL DIVISION, MITOSIS, S PHASE, SERINE/THREONINE-PROTEIN KINASE, DBF4-DEPENDENT KINASE, DDK, ATP-BINDING, NUCLEOTIDE-BINDING, ZINC- BINDING, NUCLEUS, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4f9c:A    (SER70) to   (GLY202)  HUMAN CDC7 KINASE IN COMPLEX WITH DBF4 AND XL413  |   SER/THR PROTEIN KINASE, TRANSFERASE, PHOSPHORYLATION, CELL CYCLE, CELL DIVISION, MITOSIS, S PHASE, SERINE/THREONINE-PROTEIN KINASE, DBF4-DEPENDENT KINASE, DDK, ATP-BINDING, NUCLEOTIDE-BINDING, ZINC- BINDING, NUCLEUS, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3r0t:A    (SER51) to   (PHE181)  CRYSTAL STRUCTURE OF HUMAN PROTEIN KINASE CK2 ALPHA SUBUNIT IN COMPLEX WITH THE INHIBITOR CX-5279  |   KINASE, CK2-INHIBITOR COMPLEX, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3r2b:A    (LEU79) to   (THR215)  MK2 KINASE BOUND TO COMPOUND 5B  |   KINASE DOMAIN WITH BOUND INHIBITOR, KINASE DOMAIN, PHOSPHOTRANSFERASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3r2b:B    (LEU79) to   (THR215)  MK2 KINASE BOUND TO COMPOUND 5B  |   KINASE DOMAIN WITH BOUND INHIBITOR, KINASE DOMAIN, PHOSPHOTRANSFERASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3r2b:D    (LEU79) to   (THR215)  MK2 KINASE BOUND TO COMPOUND 5B  |   KINASE DOMAIN WITH BOUND INHIBITOR, KINASE DOMAIN, PHOSPHOTRANSFERASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3r2b:F    (LEU79) to   (THR215)  MK2 KINASE BOUND TO COMPOUND 5B  |   KINASE DOMAIN WITH BOUND INHIBITOR, KINASE DOMAIN, PHOSPHOTRANSFERASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3r2b:I    (LEU79) to   (THR215)  MK2 KINASE BOUND TO COMPOUND 5B  |   KINASE DOMAIN WITH BOUND INHIBITOR, KINASE DOMAIN, PHOSPHOTRANSFERASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3r2b:J    (LYS77) to   (THR215)  MK2 KINASE BOUND TO COMPOUND 5B  |   KINASE DOMAIN WITH BOUND INHIBITOR, KINASE DOMAIN, PHOSPHOTRANSFERASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3r2b:K    (LEU79) to   (THR215)  MK2 KINASE BOUND TO COMPOUND 5B  |   KINASE DOMAIN WITH BOUND INHIBITOR, KINASE DOMAIN, PHOSPHOTRANSFERASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3r2b:L    (LYS77) to   (THR215)  MK2 KINASE BOUND TO COMPOUND 5B  |   KINASE DOMAIN WITH BOUND INHIBITOR, KINASE DOMAIN, PHOSPHOTRANSFERASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4fv5:A    (GLY35) to   (ALA172)  CRYSTAL STRUCTURE OF THE ERK2 COMPLEXED WITH EK9  |   TRANSFERASE 
5k4i:A    (GLY37) to   (ALA174)  CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH COMPOUND 22  |   PROTEIN KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4gj3:A   (GLY909) to  (PRO1049)  TYK2 (JH1) IN COMPLEX WITH 2,6-DICHLORO-4-CYANO-N-[2-({[(1R,2R)-2- FLUOROCYCLOPROPYL]CARBONYL}AMINO)PYRIDIN-4-YL]BENZAMIDE  |   KINASE, ATP BINDING, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
5khx:A   (LYS888) to  (THR1030)  CRYSTAL STRUCTURE OF JAK1 IN COMPLEX WITH PF-4950736  |   JAK1, KINASE, INHIBITOR, COMPLEX, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
5kx7:B   (GLY198) to   (SER336)  IRAK4-INHIBITOR CO-STRUCTURE  |   KINASE, PHOSPHATASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
5lck:A    (GLY37) to   (VAL173)  A CLICKABLE COVALENT ERK 1/2 INHIBITOR  |   ERK2 COVALENT INHIBITOR, TRANSFERASE 
5lwn:A   (GLY834) to   (LEU976)  CRYSTAL STRUCTURE OF JAK3 IN COMPLEX WITH COMPOUND 5 (FM409)  |   TRANSFERASE, JAK3, COVALENT INHIBITOR, REVERSIBLE COVALENT INHIBITOR, INDUCED POCKET, ARGININE POCKET, STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC